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RNA polymerase II (RNAPII) transcription is a tightly regulated process controlling cell 
type and state. Advancements in our understanding of how transcription is regulated will provide 
insight into the mechanisms controlling cell identity, cellular differentiation, and its 
misregulation in disease. It was generally presumed that RNAPII transcribed in a unidirectional 
manner to produce a coding mRNA. However, RNAPII has recently been found to initiate 
transcription upstream and antisense from active gene promoters in mammals and yeast. 
Although RNAPII initiates divergently from these promoters, efficient RNAPII elongation 
leading to the production of a full-length, stable, abundant RNA molecule is confined to the 
coding sense direction. These data suggest an unknown mechanism to suppress transcription 
from the upstream antisense region of divergent promoters.  
In Chapter 2, we describe an analysis of uaRNA at a candidate set of divergent promoters 
in mouse embryonic stem cells (mESCs). We reveal that upstream antisense RNAs (uaRNAs) 
are less than 1 kb in size, 5’-capped, heterogeneous at their 3’-ends, and accumulate to 1-4 
copies per cell at the steady state. In addition, uaRNA are transcribed with comparable kinetics 
as their linked mRNA and undergo RNAPII pausing and pause release via the recruitment and 
activity of P-TEFb. Furthermore, uaRNA have short half-lives (15-20 minutes), likely due to 
them being targeted for rapid degradation by the RNA exosome. Altogether, these data indicate 
that the mechanism regulating promoter directionality at divergent promoters occurs after P-
TEFb recruitment.  
In Chapter 3, we describe a genome-wide analysis to map the 3’-ends of polyadenylated 
RNAs in mESCs and reveal that uaRNAs terminate through a poly (A) site (PAS)-dependent 
mechanism shortly after being initiated. Interestingly, we find that an asymmetric distribution of 
encoded U1 snRNP binding sites (U1 sites or 5’ splice sites) and PASs surrounding gene 
transcription start sites (TSSs) enforce promoter directionality by ensuring uaRNAs are 
prematurely terminated and likely subsequently degraded. Together, these studies highlight the 
importance of early splicing signals in producing a full-length coding mRNA, but more 
importantly, our data reveals that the genomic DNA contains the necessary instructions to read 
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Transcription is a basic process that functions to copy the gene into a messenger RNA 
(mRNA) that can be transported to the cytoplasm and subsequently translated into a functional 
protein. Thus, transcriptional regulation is important in defining cell type and state, and its 
misregulation can lead to a diseased state. For the past 25 years, transcription was thought to 
proceed in a unidirectional manner from gene promoters. We now know that RNAPII initiates 
transcription in both directions from gene promoters (Core et al., 2008; Preker et al., 2008; Seila 
et al., 2008), producing short, low abundant, and unstable RNA in the antisense direction but 
full-length, stable mRNAs in the coding direction. These initial observations suggested an 
unknown mechanism to enforce promoter directionality through the suppression of upstream 
antisense RNA (uaRNA) transcription, which will be the main question addressed in this thesis.  
In this introduction I will describe the mechanistic steps involved in transcribing a coding 
gene. Specifically, I will focus on a description of chromatin and its involvement in gene 
activation, transcription initiation, transcription elongation, transcription termination, pre-mRNA 
processing events that occur co-transcriptionally, and a description of the discovery of divergent 
transcription. Although we have learned a great deal about these processes from studying 
bacterial systems, I will focus here on eukaryotic transcription providing examples from both 
yeast and mammals. Prior to this thesis, little was known regarding the origin, structure, and 
biogenesis of uaRNA or why a full-length, stable, coding mRNA is not produced in the upstream 
antisense direction of gene promoters. Therefore, in Chapter 2, I will describe a set of 
experiments aimed to characterize the structure and sequence of uaRNA from a small cohort of 
divergent promoters. I found that uaRNA share similar characteristics as coding mRNA, in that 
they are 5’-capped, produced at a similar rate as sense pre-mRNA, regulated by RNAPII 
pausing, and are even elongated by P-TEFb activities. In contrast to mRNA, uaRNA are less than 
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1 kb in size, unstable, and can be targeted for degradation by the RNA exosome. In Chapter 3, I 
find that uaRNA are terminated in a PAS-dependent manner shortly after being initiated. 
Furthermore, we find that an asymmetric distribution of PAS and U1 sites in the DNA, 
surrounding gene TSSs, functions to enforce transcriptional directionality at gene promoters by 
regulating promoter-proximal cleavage and polyadenylation. Altogether, this thesis uncovers a 
mechanism to suppress upstream antisense transcription at gene promoters and we suggest that 
the U1-PAS axis may have a broader role in suppressing pervasive transcription outside coding 
genes.  
 
Chromatin and gene activation 
I will begin with a description of chromatin and its role in gene activation. Chromatin is the 
association between DNA and protein that function to compact the genomic information into the 
nuclear compartment of the eukaryotic cell. Early cytological studies in liverwort mosses and 
Drosophila melanogaster revealed two types of chromatin, euchromatin and heterochromatin, 
which can be distinguished under the microscope as less compacted and densely compacted 
chromatin, respectively (Heitz, 1928; Kornberg and Lorch, 1992). The fundamental repeating 
unit of chromatin is the nucleosome, which consists of 147 bases of DNA wrapped around an 
octamer of histone proteins. Each nucleosome consists of two copies of H2A, H2B, H3, and H4 
(Kornberg and Lorch, 1992). In addition, each histone has an N-terminal extension, or histone 
“tail”, that contain sites for post-translational modifications such as methylation, acetylation, 
ubiquitination, phosphorylation, sumoylation, and ribosylation (Suganuma and Workman, 2011). 
Histone modifications have been proposed to function as a “histone code” (Jenuwein and Allis, 
2001) that may either structurally alter chromatin or be interpreted by effector proteins that 
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function to regulate gene expression (Rando and Chang, 2009). Although there has been 
advancements in our understanding of chromatin-related mechanisms of gene silencing (Beisel 
and Paro, 2011), I will focus on mechanisms of gene activation in this introduction.  
The first step in initiating transcription, whether unidirectional or divergent, at a promoter is 
to make the template DNA accessible to RNAPII and general transcription factors (GTFs). This 
is accomplished by acetylating histone H3 (Brownell et al., 1996), which functions to weaken the 
association between histones and DNA (Graff and Tsai, 2013; Hebbes et al., 1994; Hebbes et al., 
1988) but also serves as a binding site for ATP-dependent chromatin modifiers that act to 
remove nucleosomes from the template DNA (Clapier and Cairns, 2009; Smith and Peterson, 
2005). Gene activation requires more than an accessible promoter free of nucleosomes. In fact, 
enhancers, or distal regulatory regions often located large distances away, bind multiple 
transcription factors and loop to contact the promoter with the aid of mediator and cohesin 
complexes (Kagey et al., 2010; Ong and Corces, 2011). These enhancer-promoter contacts 
function to provide an efficient platform to recruit transcription factors and RNAPII. 
 
Transcription 
In this section, I will describe the basic steps of transcription: initiation, elongation, and 
termination. In doing so, it will be important to consider each stage as a potential step to 
differentially regulate sense from antisense transcription at divergent promoters. I will first begin 
with a brief description on the structure and function of RNAPII, the DNA-dependent RNA 
polymerase that transcribes all coding mRNAs (Young, 1991). 
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RNAPII structure and the CTD   
There are 3 known DNA-dependent RNA polymerases in mammals and yeast: RNAPI, 
RNAPII, and RNAPIII. RNAPI transcribes ribosomal RNA, RNAPII transcribes messenger 
RNA and various classes of noncoding RNAs, and RNAPIII transcribes transfer RNA and other 
small RNAs. We will focus on the function and activities of RNAPII.  RNAPII is composed of a 
12-member core enzyme with several members (RPB5, RPB6, RPB8, RPB10, RPB12) shared 
between all eukaryotic RNA polymerases. In addition, the largest subunit, RPB1, contains a 
carboxyl terminal domain (CTD) that consists of repeats (52 in mammals) of a heptapeptide 
sequence: Tyr-Ser-Pro-Thr-Ser-Pro-Ser. The residues in the CTD are frequently modified and 
these covalent changes are proposed to be read as a “code” that can influence gene expression 
(Buratowski, 2003). 
 
The RNAPII CTD couples RNA processing to transcription   
Current models propose that the CTD may act as a scaffold to link transcription to co-
transcriptional processing of pre-mRNAs (Buratowski, 2009; Phatnani and Greenleaf, 2006). 
The importance of the CTD in RNA processing was first revealed when RNA processing steps 
such as capping, splicing, and polyadenylation were significantly reduced in the absence of a 
functional CTD domain (Cho et al., 1997; McCracken et al., 1997a; McCracken et al., 1997b), 
indicating a direct interaction between the CTD and the RNA processing machinery.  
It has become evident that specific post-translational modifications on the CTD, like Ser 
5 and Ser 2, play critical roles in recruiting capping, splicing, and polyadenylation factors at the 
appropriate time during the transcription of pre-mRNA (Buratowski, 2009; Phatnani and 
Greenleaf, 2006). For example, Ser 5 of the CTD is phosphorylated at the start of transcription 
	   10	  
initiation (Cho et al., 2001; Trigon et al., 1998), which leads to recruitment of the capping factors 
to the CTD (Cho et al., 1998; Ho and Shuman, 1999; Schroeder et al., 2000). Subsequently, Ser 5 
is dephosphorylated and Ser 2 of the CTD is phosphorylated, which functions as a platform for 
splicing and cleavage and polyadenylation factors to bind (Buratowski, 2009; Phatnani and 
Greenleaf, 2006). More recently, phosphorylation at Ser 7 of the RNAPII CTD has been shown 
to be important for the removal of Ser 5 and recruitment of the integrator complex, which 
functions in the 3’-end processing at snRNA genes (Egloff, 2012; Egloff et al., 2012). However, 
a broader role for this modification in gene regulation is possible and will need to be further 
explored.   
 
Transcription initiation   
The first step in the transcription cycle involves the assembly of GTFs and RNAPII to 
cis-regulatory elements in the promoter sequence (Smale and Kadonaga, 2003). This process is 
enhanced by distal regulatory regions, known as enhancers, often located long distances from the 
genes that they act on (Ong and Corces, 2011). Early in vitro biochemical studies demonstrated 
that the GTFs, TFIIA, TFIIB, TFIID, TFIIE, TFIIF, TFIIH bind in a sequential manner leading 
to the recruitment of RNAPII to form the closed initiation complex (Buratowski et al., 1989; 
Conaway and Conaway, 1993; Zawel and Reinberg, 1993). The open initiation complex is 
formed when TFIIH begins to unwind the template DNA, forming a transcription bubble where 
RNAPII begins to synthesize short abortive transcripts (Dvir et al., 1997; Moreland et al., 1999; 
Tirode et al., 1999). Once RNAPII begins to synthesize RNA transcripts of sufficient length, thus 
breaking promoter contacts, RNAPII begins to transition to a more elongation competent form. 
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However, RNAPII undergoes additional barriers that must be overcome before productive 
elongation can lead to the production of a full-length transcript.   
 
Transcription elongation 
It was generally thought that recruitment of GTFs and RNAPII was the rate-limiting step 
in gene activation (Ptashne and Gann, 1997; Stargell and Struhl, 1996). However, current views 
now indicate that post-initiation modes of transcriptional regulation are very common and often 
exploited in cancer (Lin et al., 2012; Loven et al., 2013) and other diseases (Schwartz et al., 
2012). In this section, we focus primarily on elongation control through a mechanism of RNAPII 
pausing, which has emerged as a very common mode of gene regulation in mammals and is a 
topic of study in this thesis.  
 
Discovery and prevalence of RNAPII pausing  Early studies in fruit flies demonstrated that 
RNAPII encounters barriers shortly downstream of the gene TSS. In particular, studies 
conducted by John Lis’ laboratory demonstrated that RNAPII is associated with the 5’-end of the 
uninduced hsp-70 heat shock gene. Specifically, in these experiments it was shown that RNAPII 
is paused 20-40 bases downstream of the TSS, a process referred to as RNAPII pausing (Gilmour 
and Lis, 1986; Rasmussen and Lis, 1993; Rougvie and Lis, 1988).  Others subsequently found 
that RNAPII pausing occurs at a considerable number of other Drosophila melanogaster genes 
(Law et al., 1998; Muse et al., 2007; Rougvie and Lis, 1990; Zeitlinger et al., 2007). Insight into 
the prevalence of post-initiation modes of gene regulation in mammalian cells came from 
Richard Young’s laboratory, who demonstrated that most genes in human cells undergo 
transcription initiation (Bernstein et al., 2002; Bernstein et al., 2005; Santos-Rosa et al., 2002), 
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yet only a fraction of these genes produced full-length transcripts and acquired chromatin histone 
marks indicative of transcription elongation (di- and tri- methylation of lysine 79 and 36 on 
histone 3, respectively, H3K79me2  and H3K36me3) (Bannister et al., 2005; Guenther et al., 
2007; Strahl et al., 2002). More recently, the Lis Laboratory developed a high-throughput 
sequencing technique, Global Run-On sequencing (GRO-seq), to sequence nascent RNAs and 
found that most active human genes undergo RNAPII pausing downstream of the TSS (Core et 
al., 2012).  
 
Mechanism of RNA polymerase II pausing and pause release  Early studies in the mid-70’s 
revealed 5,6-dichloro-1-B-D-ribofuranosylbenzimidazole (DRB) as a chemical compound 
capable of inhibiting the production of full-length messenger RNAs (Egyhazi, 1974, 1975, 1976; 
Sehgal et al., 1976). Interestingly, the effect of DRB on transcription in vivo was absent in in 
vitro transcription systems (Chodosh et al., 1989). These data indicated that factors that normally 
function to restrict full-length transcripts in vivo may be absent in these reconstituted 
transcription systems. Using this in vitro transcription system, Hiroshi Handa’s group identified 
the DRB sensitivity-inducing factor (DSIF), composed of Supt4h and Supt5h, as the complex 
capable of inducing the production of short transcripts (28-32 bases in size) in vitro (Wada et al., 
1998). Subsequently, the multi-subunit complex negative elongation factor (NELF) was 
observed to cooperate with DSIF to repress transcription elongation (Yamaguchi et al., 1999). 
Release from the paused state requires the action of the positive elongation factor (P-TEFb), 
which phosphorylates the DSIF-NELF complex, promotes the dissociation of NELF, and 
converts DSIF to an elongation-promoting factor (Marshall and Price, 1992, 1995; Wada et al., 
1998). In addition, P-TEFb phosphorylates Ser 2 on the CTD of RNAPII, providing the 
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necessary signals to promote efficient transcription elongation and RNA processing (Peterlin and 
Price, 2006). In yeast, P-TEFb-like activities are split between two distinct protein: Ctk1 and 
Bur1 (Cho et al., 2001; Zhou et al., 2009). Ctk1 is responsible for the bulk of Ser 2 
phosphorylation on the CTD, but recent data indicates Bur1 can also contribute to Ser 2 
phosphorylation downstream of the promoter (Liu et al., 2009; Qiu et al., 2009). Bur1 mainly 
functions to phosphorylate DSIF (Zhou et al., 2009). More recently in mammals, two additional 
Ser 2 kinases (CDK12 and CDK13) have been found to phosphorylate Ser 2 on the CTD, but 
have been proposed to function downstream of P-TEFb (Bartkowiak et al., 2010). CDK12 and 
CDK13 have been linked to splicing (Berro et al., 2008; Even et al., 2006), genome stability 
(Blazek et al., 2011), and embryonic stem cell self-renewal and differentiation (Dai et al., 2012).  
 
Transcription termination 
It has become clear that transcription can be terminated through various mechanisms that 
depend on both signal sequences and the recruitment of specific factors to the 3’-end of RNA 
transcripts. In this section I will discuss two transcription termination mechanisms: canonical 
PAS-dependent and the non-canonical Nrd1-Nab3-Sen1 (NNS) pathway. PAS-dependent 
transcription termination is the most common mode of termination used at coding mRNAs in 
eukaryotes. PAS-dependent termination begins with first cleavage and polyadenylation of the 
nascent transcript followed by subsequent release of RNAPII from the genomic DNA template. I 
will focus this section on the latter step with a more thorough review of the mechanism of 
cleavage and polyadenylation in the section on co-transcriptional processing.  
The importance of a functional PAS site for efficient transcription termination was 
illustrated in in vitro cleavage assays using substrates containing mutated PAS sites (Connelly 
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and Manley, 1988; Logan et al., 1987; Moore and Sharp, 1984, 1985). From these initial studies 
two models were proposed. The first model, known as the allosteric or anti-terminator model, 
proposed that upon transcription through a PAS, there is a conformational change in the 
elongation complex leading to the dissociation of the elongation factors and association of the 
termination factors (Logan et al., 1987). The second model, known as the torpedo model, 
proposed that cleavage of the nascent transcript downstream of the PAS site provided an entry 
site for a 5’ to 3’ exonuclease that degrads the tethered RNA and leads to its dissociation from 
the template DNA (Connelly and Manley, 1988). The torpedo model was strengthened when the 
5’-3’ exonuclease in yeast (Rat1) and human (Xrn2) was found to promote efficient termination 
(Kim et al., 2004; West et al., 2004). However, a recent study unifies both models by 
demonstrating that Rat1 and Xrn2 co-transcriptionally degrade the nascent RNA tethered to 
RNAPII but also recruit 3’-end formation factors. Interestingly, both activities are important for 
efficient termination (Luo et al., 2006). Further experimentation will be necessary to refine these 
models. However, it is clear that efficient transcription termination serves various functional 
roles in the cell, such as preventing read-through transcription between neighboring genes and 
promoting transcriptional recycling (Gilmour and Fan, 2008; Richard and Manley, 2009). 
The non-canonical NNS pathway, first described in yeast, has been found to generate 3’-
ends for snRNAs, snoRNAs, and other non-coding RNAs like cryptic unstable transcripts 
(CUTs) (Houseley et al., 2006). The NNS termination machinery is composed of Nrd1/Nab3 
(RNA binding proteins) and the DNA helicase Sen1 (Kuehner et al., 2011). Termination is 
triggered by Nrd1 and Nab3 binding to GUA[A/G] and UCUU repeats at the 3’-end of the RNA, 
respectively (Carroll et al., 2004; Steinmetz and Brow, 1996, 1998). In addition, Nrd1 has been 
found to interact directly with Ser 5 on the CTD of RNAPII (Kubicek et al., 2012; Vasiljeva et 
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al., 2008). Recently, Sen1 has been shown to dissociate the RNAPII elongation complex by 
unwinding the DNA:RNA hybrid in an ATP-dependent manner (Porrua and Libri, 2013). Upon 
release of the nascent transcript from RNAPII and Sen1, the RNA transcript is targeted for 
transient polyadenylation by the Trf4/Air2/Mtr4p polyadenylation (TRAMP) and either 3’-end 
trimmed (sno/snRNAs) or completely degraded by the RNA exosome (CUTs) (Vasiljeva and 
Buratowski, 2006). How the NNS pathway decides between 3’-end trimming or complete 
degradation in an exosome-dependent manner is an ongoing question, but it has been proposed 
that RNA-binding proteins associated with the 3’-end may influence this decision (Houseley et 
al., 2006; Vasiljeva and Buratowski, 2006). Intriguingly, an Nrd1-Nab3 activity has yet to be 
described in higher eukaryotes, which may indicate an alternative mechanism to terminate the 
various classes of noncoding RNAs in these organisms. 
 
Co-transcriptional processes 
In the previous sections I have described the basic steps involved in transcription. I will 
now focus on several pre-mRNA processing steps that occur co-transcriptionally. These RNA 
processing steps function to stabilized the nascent RNA and promote the efficient transport of the 
mRNA to the cytoplasm where it can be translated. Any failure in one of these steps leads to 




The addition of a 7-methylguanosine (m7G) cap to the 5’-end of the pre-mRNA is the 
first modification to occur shortly after the initiation of transcription, when RNAPII has begun to 
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synthesize a transcript roughly 15-20 nucleotides in size. The addition of a 5’-cap structure has 
been observed to enhance splicing (Konarska et al., 1984; Krainer et al., 1984; Noble et al., 
1986), RNA stability, nuclear export, and translation (Moore and Proudfoot, 2009). Most of the 
work on characterizing the biochemical mechanism of 5’-cap formation has been conducted in S. 
cerevisiae and S. pombe. First, the m7G cap is added to the growing nascent RNA in three 
enzymatic steps: removal of the gamma phosphate by an RNA triphosphatase, transfer of 
guanine monophosphate to the RNA di-phosphate end, and methylation at the 7-nitrogen of the 
guanosine cap by a methyl transferase. In S. cerevisiae and S. pombe, the three enzymatic steps 
are performed by 3 distinct proteins (Mao et al., 1995; Shibagaki et al., 1992; Tsukamoto et al., 
1997), whereas in metazoans, including mammals, the triphosphatase and guanylytransferase 
activities are catalyzed by a single enzyme (Pillutla et al., 1998; Tsukamoto et al., 1998; 
Yamada-Okabe et al., 1998; Yue et al., 1997).  
 
RNA Splicing 
RNAPII transcribes primary transcripts that are composed of both coding exons and 
intervening noncoding introns. It is necessary for these intronic sequences to be removed from 
the RNA transcript for the mRNA to mature and encode a functional protein. From the initial 
discovery of split genes in adenovirus (Berget et al., 1977; Chow et al., 1977) a model was 
proposed for the existence of a sophisticated mechanism and machinery that functions in pre-
mRNA splicing. In this section we will describe two pathways utilized to splice pre-mRNA 
transcripts: the major and minor splicing pathways. 
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5’ and 3’ splice sites at major class introns  A comparison of genomic and cDNA sequences 
from the ovalbumin locus revealed common, short sequence elements at the exon/intron 
boundaries, indicating that cis-elements within the pre-mRNA may promote the splicing reaction 
(Breathnach et al., 1978). From an analysis that compiled all known splice-junction sequences 
and calculated the occurrence of each nucleotide at each position, a consensus 5’ splice site 
(5’SS) was determined: (C or A)AG GU(A or G)AGU (Mount, 1982) (Figure 1a). The 5’SS 
consensus sequence involves the last 3 nucleotides in the exon and the first 6 nucleotides in the 
downstream intron. Almost all higher eukaryotic introns have an invariant GU at their 5’-end.  
Because the GU positions are the only invariant nucleotides in the 9 base sequence motif 
(denoted in bold), there are a number of 5’SS derivative sequences that can actively be used in 
splicing. In fact, computational algorithms have recently been developed to predict the strength 
of a given 5’ splice site variant based on their ability to promote splicing in human pre-mRNAs 
(Yeo and Burge, 2004). Furthermore, algorithms to predict 5’SS sequences genome-wide have 
been a valuable tool to predict gene structure across the genome (Faustino and Cooper, 2003).  
 The functional significance of the 5’SS sequence was determined through mutational 
analysis and subsequent assaying of the impact on pre-mRNA processing. Experiments using the 
β-globin gene demonstrated that the 5’ most 6 nucleotides in the intron were necessary for 
splicing (Wieringa et al., 1984). Specifically, mutations in the invariant GU (positions 4 and 5 in 
the motif) completely inhibited the splicing event (Treisman et al., 1983; Wieringa et al., 1983), 
whereas mutations at other positions in the 5’SS motif were still capable of splicing to varying 
degrees (Solnick, 1981; Treisman et al., 1983). Although not as conserved as the 5’SS, 
mammalian 3’ splice site (3’SS) sequences are composed of the following: an invariable AG at 
the 3’ most nucleotides of the intron, an upstream polypyrimidine tract, and a branch point 
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(Figure 1a). Likewise, mutational analysis demonstrated the functional importance of the 3’SS in 
catalyzing the splicing reaction (van Santen and Spritz, 1985; Wieringa et al., 1984). In recent 
years, it has become clear that mutations that disrupt cis- splicing signals can result in alternative 
protein isoforms or completely inactivate protein products leading to disease (Baralle and 
Baralle, 2005; Faustino and Cooper, 2003).  
 
The splicing reaction and ribonucleoproteins involved in the major pathway  The 
development of in vitro splicing reactions not only provided the initial proof-of concept for the 
existence of an endogenous splicing activity (Hernandez and Keller, 1983; Krainer et al., 1984) 
but it also provided the controllable systems to determine the order of steps in the splicing 
reaction through the isolation of splicing intermediates and products (Padgett et al., 1984; Ruskin 
et al., 1984).  Collectively, these studies described a two-step process of pre-mRNA splicing. 
First, the pre-mRNA is cleaved at the 5’SS producing two splicing intermediates: a product 
corresponding to the upstream first exon and another species representing the intervening intron 
and downstream RNA in a lariat structure. This is due to the 2’-5’ phosphodiester linkage 
between the guanosine at the 5’SS and an adenosine near the 3’-end of the intron. The second 
step involves cleavage at the 3’SS and subsequent joining of the two exons (Padgett et al., 1984; 
Ruskin et al., 1984).  
 The major spliceosome, a complex composed of multiple small ribonucleoproteins 
(snRNPs), catalyzes the splicing reaction by binding in a sequential manner to the nascent pre-
mRNA (Figure 1b). An intron is first recognized, or defined by binding of the U1 snRNP to the 
5’SS (Bindereif and Green, 1987; Chabot and Steitz, 1987; Krainer et al., 1984; Mount, 1983; 
Ruby and Abelson, 1988; Seraphin et al., 1988; Seraphin and Rosbash, 1989), a step that is 
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greatly enhanced through the binding of SR proteins to upstream exonic splicing enhancer 
sequences (Kuo et al., 1991; Robberson et al., 1990; Talerico and Berget, 1990; Zhong et al., 
2009). The second step involves the binding of the U2 snRNP at the branch point of the 3’SS 
with the aid of an extrinsic factor known at U2AF, which binds the polypyrimidine tract (Ruskin 
et al., 1988; Zamore and Green, 1989; Zamore et al., 1992). Subsequently, the U4, U6, and U5 
snRNP associate with the complex through interactions with the U1 and U2 snRNP (Cheng and 
Abelson, 1987; Konarska and Sharp, 1987). Next, a conformational change in the complex 
results in the destabilization of U1 and U4 from the complex prior to a U6:U2 interaction to form 
the active site, which facilitates the two successive cleavage steps described above. After the 
second catalytic step, the pre-mRNA is released from the spliceosome and U2, U5, U6 snRNPs 
(bound to the lariat) are recycled from subsequent splicing (Wahl et al., 2009). 
 
Minor splicing pathway  Most higher eukaryotic pre-mRNA introns are spliced by the major 
spliceosome described above. However, minor class introns, which represent a small proportion 
of all introns, are spliced using an alternative spliceosome complex (Patel and Steitz, 2003). 
Minor class introns are characterized by a highly conserved 5’SS and branch point sequence, 
distinct from those at major introns, as well as the lack of a polypyrimidine tract at the 3’-end of 
the intron (Hall and Padgett, 1994). Furthermore, minor class introns require a unique set of 
ribonucleoprotein complexes to catalyze the splicing reaction. For example, the minor 
spliceosome is composed of U11 and U12 (functionally similar to the U1 and U2 snRNPs), 
U4atac and U6atac (functionally similar to the U4 and U6 snRNPs), and the U5 snRNP, which is 
shared between the minor and major pathways (Hall and Padgett, 1994; Tarn and Steitz, 1996a, 
	   20	  
b). Although minor introns are less frequent in the genome, their conservation among metazoans 
indicates important cellular functions.  
 
Cleavage and polyadenylation 
Evidence and function of a poly (A) tail  Studies in the early ‘70s uncovered a unique feature 
of mammalian mRNAs in that they contained, at the 3’-end terminal sequences, a stretch of poly 
(A) (Adesnik et al., 1972; Birnboim et al., 1973; Edmonds et al., 1971; Lim and Canellakis, 
1970; Mendecki et al., 1972). The poly (A) polymerase was subsequently discovered and shown 
to catalyze the addition of poly (A) to the end of mRNA (Winters and Edmonds, 1973a, b).  
Given the unique property of mRNA, Phillip Leder’s group devised a method to isolate poly (A) 
globin mRNA from mammalian red blood cells using chromatography on oligothymidylic acid-
cellulose and derivatives of this method would prove useful in isolating various other mRNAs 
(Brownlee et al., 1973; Mathews et al., 1971; Rosen et al., 1975). In fact, most coding mRNAs 
contain poly (A) tails, except a subset of histone mRNAs that are rapidly expressed at the 
beginning of S phase (Marzluff et al., 2008). The poly (A) tail has been shown to be important 
for RNA stability, mRNA export, and translation (Proudfoot et al., 2002). 
 
Identification of the poly (A) site (PAS) and GU-rich motif  Seminal work conducted by 
Proudfoot and Brownlee described the sequencing of the first six mRNA 3’-ends from rabbit, 
human, mouse, and chicken (Proudfoot and Brownlee, 1976). These studies revealed a conserved 
AAUAAA hexamer PAS roughly 20-30 nucleotides from the 3’-terminal poly (A) tail. From 
these findings, they proposed that the PAS was necessary for cleavage and polyadenylation and 
likely the first step in promoting efficient transcription termination. Recent studies analyzing 
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hexamers upstream of expressed sequence tags (ESTs) (Beaudoing et al., 2000; Gautheret et al., 
1998; Tian et al., 2005) and 3’-ends tags generated from high-throughput sequencing (Derti et 
al., 2012; Hoque et al., 2013; Shepard et al., 2011) indicate that most coding mRNAs contain a 
canonical PAS, AAUAAA, or the common variant, AUUAAA, upstream of the cleavage site. 
However, 9 additional PAS variant hexamers that are enriched at the expected 21 nucleotides 
upstream the cleavage site have been identified, suggesting their ability to function as a signal for 
cleavage and polyadenylation (Beaudoing et al., 2000; Tian et al., 2005). In addition to the PAS, 
a GU-rich sequence element downstream of the cleavage site and an upstream UGUA motif can 
enhance 3’-end processing (Brown and Gilmartin, 2003; Gil and Proudfoot, 1984; McDevitt et 
al., 1984). It is likely that additional cis-elements are necessary for proper 3’-end formation as 
indicated by a recent study (Hu et al., 2005) and their identification will be important in 
understanding how cleavage and polyadenylation events are controlled and regulated.  
 
Protein components that catalyze the cleavage and polyadenylation reaction  3’-end 
maturation involves a two-step process: cleavage of the nascent pre-mRNA downstream of the 
PAS and subsequent addition of approximately 200 adenines to the 3’-end of the mRNA. 
Cleavage and polyadenylation is a tightly coupled process in a living cell and the machinery 
catalyzing these reactions are composed of multiple core components: cleavage and 
polyadenylation specificity factor (CPSF), cleavage stimulation factor (CstF), cleavage factor I 
(CFI), cleavage factor II (CFII), and the poly (A) polymerase (PAP). Most of our understanding 
on the specific functions for each component has been determined using biochemical assays that 
reconstitute cleavage and polyadenylation in vitro (Hart et al., 1985; Moore and Sharp, 1984, 
1985). For example, early studies to uncouple these processes demonstrated that an intact 
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AAUAAA sequence was necessary for cleavage and polyadenylation (Manley et al., 1985; 
Zarkower et al., 1986) and, through UV-crosslinking experiments, shown to be bound by the 
cleavage and polyadenylation specificity factor (CPSF) (Keller et al., 1991). In addition, binding 
of CPSF is greatly enhanced by the binding of the cleavage stimulatory factor (CstF) (Gilmartin 
and Nevins, 1989; Weiss et al., 1991), which interacts directly with the downstream GU-rich 
region (MacDonald et al., 1994; Takagaki and Manley, 1997; Wilusz and Shenk, 1988). CFI and 
CFII are less defined but CFI was initially identified as a factor that is required for the cleavage 
step (Takagaki et al., 1989), perhaps acting by stabilizing CPSF binding to the PAS  (Ruegsegger 
et al., 1996). More recently, using SELEX technology, CFI was demonstrated to bind aptamers 
enriched for the UGUA motif (located upstream of the cleavage site as described above) and 
upon depletion of CFI, PAS-dependent cleavage was inhibited in in vitro cleavage assays 
(Brown and Gilmartin, 2003). The poly (A) polymerase, or PAP, has little poly (A) activity in 
vitro alone, but in the presence of CPSF and poly (A) binding protein nuclear 1 (also known as 
Pab2), PAP catalyzes the addition of approximately 200 adenines to the 3’-end of pre-mRNA 
substrates (Christofori and Keller, 1988, 1989; Takagaki et al., 1988; Wahle, 1991; Wahle and 
Ruegsegger, 1999). Although the mechanism and key players involved in cleavage and 
polyadenylation have been well characterized, it was not until recently that the component 
responsible for the endonucleolytic cleavage event (CPSF-73) was identified (Mandel et al., 
2006). Furthermore, that a recent study reported over 80 different proteins that interact with the 
core cleavage and polyadenylation machinery (Shi et al., 2009), highlights the need for future 
experiments to test the function of these additional factors. It seems probable that some of these 
factors may link polyadenylation to other processes such as transcription, splicing, gene looping, 
and mRNA export (Richard and Manley, 2009).  
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Alternative cleavage and polyadenylation (APA)  Given that an appreciable number of human 
mRNAs contain multiple PAS signals at their 3’ terminal ends (Beaudoing et al., 2000; Tian et 
al., 2005), its not surprising that APA is a major mode of regulating gene expression (Di 
Giammartino et al., 2011; Elkon et al., 2013; Tian and Manley, 2013). APA refers to the 
utilization of an alternative PAS in the UTR leading to mRNAs with the same coding region but 
with different length 3’-UTRs. APA’s impact on cell growth and development became apparent 
in a set of studies that discovered an intimate connection between proliferative status and usage 
of either a proximal or distal PAS signal in the 3’-UTR of coding genes (Mayr and Bartel, 2009; 
Sandberg et al., 2008). For example, a seminal study performed by Sandberg and colleagues 
observed a widespread shortening of 3’-UTR’s upon activation of highly proliferative murine 
CD4+ T lymphocytes and that 3’UTR shortening has global impacts on gene expression 
(Sandberg et al., 2008). Subsequently, this finding was echoed in additional studies comparing 
normal and transformed cancer cells in various tissues (Mayr and Bartel, 2009; Morris et al., 
2012; Singh et al., 2009), myoblasts to differentiated myotubes (Ji et al., 2009), and even 
fibroblast to induced pluripotent stem cells (iPSCs) (Ji and Tian, 2009).  
 It is unclear how APA contributes to a change in the proliferative status of a cell. 
However, it is clear that regulating the length of the 3’-UTR could impact gene expression since 
mRNAs contain destabilizing sequences like microRNA binding sites (Bartel, 2009), AU-rich 
elements (AREs), GU-rich elements (GREs), and Puf protein binding elements (Garneau et al., 
2007) in their 3’-UTRs. Consistent with this, through correlations revealed by genome-wide 
analysis and experimental testing of specific examples in mini-gene constructs, it was 
determined that mRNAs containing shorter 3’-UTRs evaded microRNA-mediated repression 
(Mayr and Bartel, 2009; Sandberg et al., 2008). Aside from its impact in altering the length of 
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UTRs, APA can also result in qualitative changes by activating PAS sites in introns or coding 
exons that can result in the production of a different protein isoform. For example, intronic 
cleavage and polyadenylation produces dominant-negative, secreted receptor tyrosine kinases, 
which influences angiogenesis (Vorlova et al., 2011). 
 
Regulating cleavage and polyadenylation  Initial bioinformatic analysis suggested that for 
genes containing multiple PAS sites in the 3’-UTR, the strongest PAS, in terms of ability to 
induce cleavage, was often the most distal 3’ site (Beaudoing et al., 2000; Tian et al., 2005). This 
observation led to the hypothesis that regulating the levels of the canonical cleavage and 
polyadenylation factors may influence whether the proximal (weak) or distal (strong) PAS at the 
3’-end is utilized. For example, in the case where cleavage factors are limiting, stronger distal 
PAS sites would be predicted to be favored. However, when cleavage factor levels are in excess, 
weaker proximal PAS sites may be utilized. Indeed, this hypothesis is supported by various 
studies that find a direct correlation between expression of core cleavage and polyadenylation 
factors and the proliferative status (shorter 3’-UTRs), and that these factors are down-regulated 
upon differentiation when cells proliferate less and acquire longer 3’-UTR’s (Ji et al., 2009; Ji 
and Tian, 2009). Although the mechanisms controlling core cleavage factor expression are 
unclear under these cellular conditions, a recent study shows that many core cleavage factors 
contain binding motifs for E2F family members in their promoters; E2Fs have an established role 
in controlling proliferation (Elkon et al., 2012). 
Recently several alternative mechanisms have been proposed as regulators of APA. For 
example, knockdown of the poly (A) binding protein nuclear 1 (Pab2) resulted in a shift from the 
usage of a distal PAS to a more proximal PAS. Pab2 was shown to bind the proximal PAS and 
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directly compete with the core cleavage machinery under normal conditions (Jenal et al., 2012). 
Second, the cleavage factor 1m68 (CFIm68) has been observed to promote the usage of the more 
distal PAS, since upon its knockdown there was a widespread shift to the utilization of the more 
proximal PAS signals (Martin et al., 2012). These results may indicate that CFIm68 activates the 
distal PAS through its affinity to the strongest PAS signal in the 3’-UTR. Lastly, slight 
reductions in the level of functional U1 snRNP in the cell can result in a switch from the 
proximal to more distal PAS sites at coding genes (Berg et al., 2012), indicating an intimate 
relationship between U1 snRNP binding and cleavage and polyadenylation. Altogether, there has 
been an increasing amount of excitement to further define the mechanisms controlling APA, but 
more studies are needed in order to fully appreciate the complexities of APA in development and 
disease.  
 
U1 snRNP impacts cleavage and polyadenylation  In this section, I plan to elaborate in more 
detail on the recent discovery linking U1 snRNP binding to the control of cleavage and 
polyadenylation. The first indication of this mechanism was described in experiments studying 
the expression of late genes in bovine papillomavirus. Specifically, it was found that a 5’SS 
(bound by U1 snRNP) upstream of the late gene PAS functioned to inhibit polyadenylation of 
the late gene transcript (Furth et al., 1994), likely through a direct interaction with U1-70K (a U1 
snRNP-associated protein) and PAP (Gunderson et al., 1998). Further support for this 
mechanism was obtained when U1 snRNP was modified to target mRNA 3’-ends (upstream of 
PAS in 3’-UTR) leading to gene silencing (Beckley et al., 2001; Goraczniak et al., 2009), 
presumably by increasing target instability through the inhibition of the polyadenylation process. 
However, a recent set of studies indicate U1 snRNP binding at 5’SS’s at exon/intron boundaries 
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(or cryptic 5’SS within introns) can function to inhibit cleavage and polyadenylation at intronic 
PAS sites (Berg et al., 2012; Kaida et al., 2010). For example, seminal work from Gideon 
Dreyfuss’ laboratory revealed extensive premature cleavage and polyadenylation (PCPA) within 
the first intron of coding genes upon U1 inhibition (Kaida et al., 2010). Subsequent studies from 
the same group show that PCPA is a conserved feature of metazoans, as it is detected in human, 
mouse, and flies (Berg et al., 2012). Furthermore, they demonstrate at a single gene that U1 
snRNP can suppress a downstream PAS at least 1 kb away (Berg et al., 2012). Together, these 
data indicate that regulating the levels of functional U1 in the cell may have profound effects on 
RNA length, transcript isoform, and expression (Berg et al., 2012).  
 
Discovery of divergent transcription  
The recent advancements in the development of high-throughput RNA sequencing 
technologies allowed for the detection of rare transcripts and led to the realization that RNAPII 
transcribes pervasively throughout the eukaryotic genome to produce both intergenic and genic-
associated noncoding RNAs (Berretta and Morillon, 2009; Dinger et al., 2009; Jacquier, 2009; 
Kapranov et al., 2007). I will focus this section on a class of genic-associated noncoding RNA 
that result from divergent transcription at mammalian gene promoters.  
From the initial description of the basic elements of a gene many years ago, it was 
presumed that RNAPII was recruited to the gene promoter and began transcription in a 
unidirectional manner to transcribe a protein-coding gene using the various mechanisms 
described in the previous sections of this introduction. However, RNAPII has recently been 
discovered to initiate transcription in the antisense orientation from the promoter of most active 
coding genes in mammals and yeast, a process referred to as divergent transcription (Core et al., 
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2008; Neil et al., 2009; Preker et al., 2008; Seila et al., 2008; Xu et al., 2009). We focus here on 
the observations described in mammals.  
In one study, high-throughput sequencing to profile small RNAs in mouse embryonic 
stem cells (mESCs) detected a new class of small RNA that are approximately 20 nucleotides in 
size, contain a 5’ phosphate and 3’ hydroxyl, and map within 1500 bps from gene TSSs in non-
overlapping peaks (separated by roughly 250 bps) on the sense and antisense strand (Seila et al., 
2008). These promoter-proximal small RNAs that mapped on the sense and antisense strand 
were referred to as transcription start site-associated RNAs (TSSa-RNAs). Various other 
promoter-proximal sense and antisense (with respect to gene TSSs) small RNAs, with similar 
features as TSSa-RNAs, were described in subsequent studies (Fejes-Toth, 2009; Taft et al., 
2009). Northern blot analysis revealed that antisense TSSa-RNAs were low abundant and 
represented a subset of an RNA population roughly 20-90 nucleotides in size (Seila et al., 2008). 
Curiously, it was unclear whether antisense TSSa-RNAs represented the 5’-end or an internal 
sequence of larger precursor RNA products, a topic that will be addressed in Chapter 2.  
As a first test to determine whether antisense TSSa-RNAs were synthesized by RNAPII 
transcribing in the opposite orientation from promoters, Seila and colleagues performed 
chromatin immunoprecipitation sequencing (ChIP-Seq) to construct genome-wide binding 
profiles for RNAPII, H3K4me3 (histone H3 methylation modification at lysine 4 of the histone 
tail, initiation mark), and H3K79me2 (histone H3 methylation modification at lysine 79 of the 
histone tail, productive elongation mark)(Seila et al., 2008). These experiments revealed a peak 
of RNAPII and H3K4me3 upstream of the TSS that co-aligned with the peak of antisense TSSa-
RNAs, which suggested the existence of an antisense RNAPII transcription event. Direct 
evidence for an upstream antisense polymerase complex engaged in transcription was revealed in 
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a concurrent study using a novel technique, Global Run-On sequencing (GRO-Seq), to sequence 
nascent RNAs. They found evidence for widespread divergent transcription at gene promoters in 
human lung fibroblasts (Core et al., 2008). These studies provided support for an RNAPII 
transcription event on the upstream antisense strand of divergent promoters. However, despite 
RNAPII initiating transcription divergently, productive elongation is confined to the downstream 
sense direction. This is supported by a lack of histone H3 modifications at lysine 36 and lysine 
79 (histone marks indicative of transcription elongation) in the upstream antisense region of 
divergent promoters (Guenther et al., 2007; Barski et al., 2007; Seila et al., 2008). These data 
provided the first indication that productive elongation over long distances may be suppressed in 
the upstream antisense direction of divergent promoters. 
A concurrent study from Torben Jenson’s laboratory demonstrated that in the absence of 
the RNA exosome, there was a stabilization of polyadenylated sense and antisense PROMoter 
uPstream Transcripts (PROMPTs) 1 kb upstream of promoters in human cells (Preker et al., 
2011). PROMPTs were suggested to be polyadenylated noncoding transcripts that are roughly 
200-600 nucleotides in size, indicating PROMPTs were inefficiently elongated (compared to 
coding mRNA) prior to their termination. However, in these studies it was unclear as to how 
PROMPTs were generated, the mechanism leading to their early termination, and their 
relationship to TSSa-RNAs, if any, since they both arose in distinct locations upstream of 
promoters (Figure 2).  
 In this thesis, I aimed to define the mechanism that suppresses the production of full-
length, stable mRNAs in the upstream antisense direction of divergent gene promoters in 
mESCs. To address this question, we first performed a thorough biochemical analysis of the 
structure and sequence of divergently transcribed upstream antisense RNA and tested whether 
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uaRNA are transcribed using the same transcriptional mechanisms (described in this 
introduction) as sense mRNA. In Chapter 2, we found that antisense TSSa-RNA mapped 15-40 
bases downstream of the upstream antisense RNA (uaRNA) TSS. uaRNA were less than 1 kb in 
size, 5’-capped, and contained non-polyadenylated heterogeneous 3’-ends. Furthermore, we 
found that uaRNA are produced with comparable kinetics as coding mRNA and even undergo 
RNAPII pausing and pause release. Lastly, we found that uaRNA are targeted for rapid 
degradation by the RNA exosome. We suggest that the uaRNA cloned and sequenced in this 
experiment may represent degradation products, given that uaRNA are exosome substrates and 
that uaRNA ends are heterogeneous and non-polyadenylated. In Chapter 3, we performed poly 
(A) 3’-end deep sequencing and find that uaRNA are cleavage and polyadenylated at their 3’-end 
using PAS-dependent mechanisms shortly after being initiated. Given the known role for the U1 
snRNP in suppressing downstream PAS signals (Kaida et al., 2009; Berg et al., 2012), we find 
that an asymmetric distribution of U1 and PAS signals in the DNA sequence flanking gene 
TSS’s function to promote premature cleavage and polyadenylation (and likely subsequent 
degradation) in the upstream antisense direction of gene promoters. Altogether, these findings 
indicate promoter directionality is encoded in the DNA-sequence as a U1-PAS axis and may 




























Figure 1. Mechanism of pre-mRNA splicing at a major intron. a. Diagram showing the 5’ splice 
site, branch point, and 3’ splice site consensus sequences, where N is any nucleotide, R is a purine, 
and Y is a pyrimidine. The invariant GU and AG are depicted in red at the 5’ splice site and 3’ splice 
site, respectively. The polypyrimidine tract is a pyrimidine-rich stretch between the branch point and 
the 3’ splice site sequence. b. The mechanism of spliceosome assembly at a major intron of a pre-
mRNA. U1 and U2 snRNPs bind to the 5’ splice site and branch point of the 3’ splice site, respec-
tively. Then, U4, U5, and U6 snRNPs assemble to the complex through interactions with the U1 and 
U2 snRNPs. A conformational change in the complex leads to the U1 and U4 snRNPs leaving the 
complex and U2, U5, and U6 snRNPs make direct contacts to form the active spliceosome complex. 
Lastly, two successive cleavage steps result in the joining of the two exons and release of the lariat 
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STOP
Figure 2. Promoter-proximal noncoding RNAs at divergent promoters. Displaying promoter-
proximal sense and antisense TSSa-RNAs (red and blue, respectively), sense and antisense 
PROMPTs (red and blue, respectively), and the coding mRNA shown with a black arrow pointing 
towards the right. TSSa-RNAs are approximately 20 nucleotides in size, contain a 5’ phosphate and 
3’ hydroxyl, and map within 1500 bps from gene TSSs in non-overlapping peaks (separated by 
roughly 250 bps) on the sense and antisense strand (Seila et al., 2008) . In these studies it was 
unclear whether antisense TSSa-RNAs represented the 5‘-end or internal fragments of larger 
precurosor products, a topic addressed in Chapter 2. PROMPTs are several hundred nucleotides 
long, contain 3’-adenylated tails (of unknown size), and are stabilized in the absence of the RNA 
exosome approximately 1 kb upstream of human gene TSSs (Preker et al., 2008). From these intitial 
studies, it was unclear whether PROMPTs were related to TSSa-RNAs given their distinct locations 
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Abstract 
 
Divergent transcription occurs at the majority of RNA polymerase II (RNAPII) promoters in 
mouse embryonic stem cells (mESCs) and this activity correlates with CpG islands. Here we 
report the characterization of upstream antisense transcription in regions encoding transcription 
start site associated RNAs (TSSa-RNAs) at four divergent CpG island promoters: Isg20l1, 
Tcea1, Txn1, and Sf3b1. We find that upstream antisense RNAs (uaRNAs) have distinct capped 
5ʹ′ termini and heterogeneous non-polyadenylated 3ʹ′ ends. uaRNAs are short-lived with average 
half-lives of 18 minutes and are present at 1-4 copies per cell, approximately one RNA per DNA 
template. Exosome depletion stabilizes uaRNAs. These uaRNAs are probably initiation products 
since their capped termini correlate with peaks of paused RNAPII. The pausing factors NELF 
and DSIF are associated with these antisense polymerases and their sense partners.  Knockdown 
of either NELF or DSIF results in an increase in the levels of uaRNAs.  Consistent with P-TEFb 
controlling release from pausing, treatment with its inhibitor, flavopiridol, decreases uaRNA and 
nascent mRNA transcripts with similar kinetics. Finally, Isg20l1 induction reveals equivalent 
increases in transcriptional activity in sense and antisense directions. Together these data show 
divergent polymerases are regulated after P-TEFb recruitment with uaRNA levels controlled by 
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Introduction 
RNA polymerase II (RNAPII) transcription is a highly regulated process controlling cell 
type and state. Recruitment of chromatin modifying factors and RNAPII to promoters by DNA 
binding transcription factors are key regulatory steps (Hochheimer and Tjian, 2003; Kuras and 
Struhl, 1999; Ptashne and Gann, 1997; Roeder, 2005). However, genome-wide profiling of 
RNAPII indicates that this polymerase is bound and engaged in the early steps of transcriptional 
initiation at most active and many inactive genes in human embryonic stem cells suggesting 
post-initiation modes of regulation may occur more frequently than previously appreciated 
(Guenther et al., 2007). Moreover, divergent transcription, defined by detection of populations of 
low abundance small RNAs (19-25 nts) generated by non-overlapping (separated by 
approximately 250 bps) bidirectional transcription, was detected at the majority of transcriptional 
start sites (TSSs) in mouse embryonic stem cells (mESCs) (Seila et al., 2008). Polymerases 
engaged in divergent transcription near promoters were simultaneously described in human lung 
fibroblasts (Core et al., 2008). Surprisingly, RNAPII only productively elongates in the protein-
coding sense direction from these divergent promoters. Related results have been reported for 
several other eukaryotic systems (Fejes-Toth, 2009; Neil et al., 2009; Preker et al., 2008; Taft et 
al., 2009; Xu et al., 2009). Altogether, these data suggest that control of RNAPII elongation and 
RNA stability may be major points of transcriptional regulation and that mechanisms controlling 
these processes may dictate whether a stable RNA molecule is synthesized.  
In recent years it has become clear that RNAPII pausing is a major mode of 
transcriptional regulation (Core et al., 2008; Rahl et al., 2010). The Negative Elongation Factor 
(NELF) and DRB-Sensitivity Inducing Factor (DSIF) protein complexes bind and arrest RNAPII 
20-30 nts downstream of the TSS (Peterlin and Price, 2006). Recruitment of P-TEFb to a paused 
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RNAPII complex and subsequent phosphorylation of the RNAPII carboxyl-terminal domain 
(CTD) at serine 2, DSIF, and NELF, results in the dissociation of NELF from the elongation 
complex and continuation of transcription (Peterlin and Price, 2006). More recently it was 
recognized, in mESCs, that c-Myc stimulates transcription of over a third of all cellular 
promoters by recruitment of P-TEFb (Rahl et al., 2010). Intriguingly in these same cells, NELF 
and DSIF have bimodal binding profiles at divergent TSSs. This suggests divergent RNAPII 
complexes might be poised for signals controlling elongation and opens up the possibility that in 
the antisense direction P-TEF-b recruitment may be regulating release for productive elongation.  
Cellular mechanisms for removal of improperly processed, spliced, or aberrantly 
transcribed products likely account for the instability of transcripts from divergent promoters. In 
S. cerevisiae cryptic unannotated transcripts (CUTs) derived from promoter-proximal regions are 
stabilized in the absence of the exosome (Houseley et al., 2006; Neil et al., 2009; Xu et al., 
2009). The exosome, with 3ʹ′ to 5ʹ′ exonuclease activity, is a multi-subunit protein complex 
important for degradation and processing of mRNA, rRNA, snoRNA, and tRNA (Houseley et 
al., 2006; Mitchell et al., 1997; Schmid and Jensen, 2008). The phosphorylation state of the 
RNAPII CTD (Gudipati et al., 2008; Vasiljeva et al., 2008) and sequence elements within the 
RNA can influence targeting of transcripts to the exosome (Anderson et al., 2006). Upon 
exosome depletion in human cells, promoter upstream transcripts (PROMPTs) are stabilized 
farther upstream (~1kb )  from antisense TSSa-RNAs and are detected in both sense and 
antisense orientations in the upstream promoter region (Preker et al., 2008). However, it is 
unclear how various promoter associated RNAs, including PROMPTs, relate to transcription 
from divergent mammalian promoters.  
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Although multiple studies have identified distinct RNA species from mammalian 
promoters, the precise mapping of RNAs produced from divergent CpG island promoters has not 
been described. In light of these questions, we sought to investigate RNAPII divergent 
transcription through a detailed biochemical analysis of the antisense transcripts. We have 
characterized upstream antisense RNAs or uaRNAs from four divergent promoters in mESCs. 
We show that antisense RNAs are predominantly 5ʹ′ capped and have heterogeneous 3ʹ′ ends 
ranging in size from 40-1100 bases in length. Both sense and antisense RNAPII complexes were 
involved in RNAPII pausing and both depend on PTEF-b recruitment and phosphorylation for 
subsequent elongation. We further show that low steady-state levels of uaRNAs, at least in part, 
are due to their targeting by the RNA exosome. Finally, we characterize induction of antisense 
and sense transcription from the divergent promoter of the Isg20l1 gene to show that PTEF-b 
activation at both sense and antisense RNAPII complexes occur with similar kinetics.  
 
Results 
Divergent RNAPII produces low abundant capped upstream antisense RNAs (uaRNAs) 
with 3ʹ′  heterogeneity 
To test whether short antisense TSSa-RNAs previously described (Seila et al., 2008) are 
derived from longer transcripts and to determine the structure of their 5ʹ′ termini, we used Rapid 
Amplification of 5ʹ′ Complementary DNA Ends (5ʹ′-RACE) to characterize divergent upstream 
antisense RNAs from the Isg20l1, Tcea1, Txn1, and Sf3b1 genes in V6.5 mESCs (Figure 1, 
Figure S2A.). These genes were selected as representatives of divergent TSSs associated with 
CpG islands and spanning a range of expression levels. The positions of oligonucleotides for 
specific priming for the 5ʹ′-RACE overlapped sequences found in antisense TSSa-RNAs from 
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each promoter. The dependence of the specific 5ʹ′-RACE products on treatment with Tobacco 
Acid Pyrophosphatase (TAP) indicated the presence of a capped structure (Figure S1, lanes 2 
and 3). The sequenced 5ʹ′-RACE products for the antisense TSSs revealed RNAs initiated 
upstream of the previously characterized antisense TSSa-RNAs for all four promoters (Figure 1, 
Figure S2A, leftward arrows). Two predominant uaRNA TSSs for Isg20l1 were identified with 
the most upstream site 43 nts from the previously characterized clusters of antisense TSSa-
RNAs. The Tcea1 gene consists of two predominant antisense capped species with the most 
upstream 5ʹ′ terminus 37 nts from the antisense TSSa-RNAs. One predominant capped 5ʹ′ 
terminus was mapped for both Txn1 and Sf3b1 that extended 18 and 15 nts upstream from the 
antisense TSSa-RNA, respectively. The 5ʹ′ capped termini of these uaRNAs are likely generated 
by RNAPII initiation events suggesting that the antisense TSSa-RNAs are products of 
subsequent reactions during elongation.  
The 5ʹ′ capped antisense RNA for each promoter align under a peak of RNAPII density 
near the end of the CpG island (Figure 1). The segments between sense and antisense capped 
RNAs are on average 200-250 bps, comparable to the length of nucleosome-free regions 
associated with CpG islands (Ramirez-Carrozzi et al., 2009). To test if transcripts extended 
beyond the sites of antisense 5ʹ′ capped termini for these four genes, Reverse Transcriptase-
quantitative PCR (RT-qPCR) with strand-specific RT primers was used to determine the 
orientation of RNA species in the upstream CpG island promoter (Figure S3). As these 
transcripts might be of low abundance, cellular RNAs were prepared with two rigorous DNase 
treatment steps and only signals dependent on RT were analyzed. Detectable antisense 
transcription at all four genes was confined to the region downstream of the mapped uaRNA 5ʹ′ 
cap site. This provides additional evidence for initiation at these cap sites. Sense transcription 
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within the CpG island upstream of the antisense cap site was probed for all four regions but only 
detected at Txn1 and was estimated by PCR cycles to be 80-fold less abundant than the antisense 
product. The inability to detect significant sense or antisense RNA signal upstream of the 
mapped uaRNA TSSs argues that the majority products from these regions initiate from the 
identified antisense TSSs. 
 We previously have characterized antisense RNAs from divergent TSSs by a selective 
enrichment protocol followed by Northern blot and observed a family of short RNAs spanning 
30 to 200 nts (Seila et al., 2008). To more precisely define such RNAs, a 3ʹ′-RACE protocol was 
used to characterize the 3ʹ′ ends of uaRNAs from the four divergent promoters. In this approach, 
adaptor sequences were ligated onto the free 3ʹ′-OH of large fractionated RNAs, followed by 
cDNA synthesis and PCR amplification using target-specific primers. The amplified products 
were cloned and sequenced to confirm their origin and define their 3ʹ′ termini. Multiple non-
polyadenylated 3ʹ′ ends were observed for uaRNAs at each TSS and were aligned to their 
respective promoters (Figure 1). As few as 5 distinct antisense RNA 3ʹ′ ends were detected for 
Txn1 and as many as 8 at Tcea1. The longest transcripts cloned were 703, 546, 415, and 1100 nts 
for Isg20l1, Tcea1, Txn1, and Sf3b1, respectively. However, it is likely that additional 3ʹ′ ends 
exist since only a fraction of the 3ʹ′-RACE products were cloned and sequenced (Figure S4). All 
3ʹ′-RACE products were dependent on RT for amplification (Figure S4). Transcripts under 100 
nts were detected in the large fractionated RNA preparation. This probably reflects imperfect 
fractionation as similar patterns of transcripts were observed for all four genes. Because of this 
fractionation step, the relative levels of the various length RNAs cannot be estimated from the 3ʹ′-
RACE products. 
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 We compared the DNA sequences encompassed by uaRNAs with the location of 
RNAPII, TATA-binding protein (TBP) and chromatin modifications associated with active 
transcription determined by ChIP-seq in V6.5 mESCs (Kagey et al., 2010; Marson et al., 2008; 
Seila et al., 2008) (Figure 1). The shorter uaRNAs fell within the peak of bound RNAPII, 
however the longest transcripts extended farther downstream. It is likely that the density of 
RNAPII in these downstream regions is below the threshold signal considered positive in the 
ChIP-seq analysis. Histone H3 lysine 4 trimethylation (H3K4me3) and TBP mark transcription 
initiation and H3 lysine 79 dimethylation (H3K79me2) correlates with elongation. The TBP 
density denoting the pre-initiation complex was detected as a broad peak directly between the 
divergent RNAPII complexes. The H3K4me3 profile generally extended the full length of the 
uaRNAs in the antisense direction with the exception of the longest Sf3b1 transcript. In contrast, 
ChIP-seq signal for H3K79me2 is absent in antisense transcribed regions for the four genes. This 
lack of signal might be due to limits in the sensitivity of the technique, but the same chromatin 
modification is clearly present in the sense direction downstream of the TSS for these four genes. 
This suggests differential activity of elongation complexes in the two directions.   
To relate levels of uaRNAs to antisense TSSa-RNAs which were previously measured at 
1 copy per 10 mESCs (Seila et al., 2008), RT-qPCR probes noted in Figure S2A ("qPCR 
amplicon") were used for absolute quantification. Copy number defined by molar equivalents as 
compared to a standard signal in the form of ssDNA was determined per ES cell equivalent of 
total RNA. The uaRNAs are present at 4.5, 1.8, 1.1, and 1.7 copies per cell for Isg20l1, Tcea1, 
Txn1, and Sf3b1, respectively (Figure S2B). These results indicate that uaRNAs are roughly 10-
fold more abundant then previously characterized antisense TSSa-RNAs; present at 
approximately one copy per copy of genome sequences. 
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uaRNAs are substrates of the exosome 
As previous studies have linked the exosome to nuclear surveillance of unannotated or 
cryptic transcripts, uaRNA stabilization and 3ʹ′ termini were assayed upon exosome depletion. 
Exosc5 was targeted for knockdown with an shRNA-lentiviral delivery construct and depletion 
was confirmed 48 hours after infection (Figure S5). RT-qPCR was used to determine relative 
steady-state levels of uaRNAs (upstream antisense probe) and spliced sense mRNA (exon1-
exon2 probe) between knockdown (shExosc5) and empty vector control (pLKO.1) for all four 
genes. Across multiple biological replicates, Exosc5 depletion led to a 2.5-3.5 fold increase in 
uaRNA levels, while spliced sense mRNAs were also slightly elevated yet below statistical 
significance (Figure 2A). Next, we assayed for uaRNAs by DNA Southern blot of 3ʹ′-RACE 
products in control and exosome depleted cells. After optimization of minimal PCR cycles and 
multiple probe validation of signal (Figure S6), the most abundant uaRNA forms for each gene 
were observed. In Exosc5 knockdown samples, the numbers and abundance of long RNAs 
increased compared to control virus infected cells further supporting uaRNAs as substrates for 
the exosome (Figure 2B). These results show that upstream antisense RNAPII elongates to 
produce heterogeneous RNAs that are substrates for the exosome.  
 
RNAPII pausing factors regulate uaRNA transcription 
 The RNAPII pausing factors that associate with promoter proximal stalled RNAPII are 
composed of NELF (NELF-A,B,C/D, and E) and DSIF (Supt4h and Supt5h). In addition, 
RNAPII acquires phosphorylation at Ser5 on the carboxyl-terminal domain early in transcription 
and this modification peaks in abundance around the pause site. We first aligned ChIP-seq 
	   57	  
profiles of RNAPII-Ser5P, Supt5h and NELF-A determined in V6.5 mESCs to uaRNA 
transcribed regions. For all four genes, the peaks of RNAPII-Ser5P, Supt5h and NELF-A directly 
overlap the uaRNA TSS supporting post-initiation regulation by RNAPII pausing in the 
antisense direction (Figure 3A). To test whether RNAPII upstream complexes are poised for 
transcription in both directions, we performed shRNA-mediated knockdown of NELF-A, NELF-
E and Supt4h, with each providing potent targeted mRNA loss (Figure 3B). Depletion of either 
NELF subunit resulted in near 2-fold increases in uaRNA and spliced mRNA transcripts for all 
four genes across six biological replicates (Figure 3C). Supt4h knockdown also resulted in 2-fold 
increases for both uaRNAs and spliced mRNA transcripts. Together these data argue NELF and 
DSIF complexes are equivalently active in binding and regulating paused RNAPII complexes in 
both directions at divergent promoters.  
 
P-TEFb regulates elongation of uaRNAs  
 P-TEFb promotes RNAPII elongation in the sense direction for most if not all genes, 
however, its role in antisense transcription at divergent promoters has not been examined. We 
used flavopiridol, a small molecule drug with high specificity for CDK9 inhibition to test P-
TEFb’s requirement for RNA synthesis at divergent TSSs. uaRNA, spliced mRNA, and nascent 
mRNA transcripts (exon1-intron1 probe) were measured at all four genes in mock (DMSO) or 
1µM flavopiridol treated mESCs. Treatment with this flavopiridol concentration for 1 hour was 
previously shown to not affect global RNAPII-Ser5P levels while dramatically reducing 
RNAPII-Ser2P and Supt5h phosphorylation in these cells, indicating a block of transcriptional 
elongation but not initiation (Rahl et al., 2010). In flavopiridol-treated cells, the nascent mRNA 
transcripts for all four genes were reduced to 5-12% of mock-treated controls confirming a block 
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in elongation (Figure 4A). Interestingly, steady-state uaRNA transcript levels decreased to 19-
25% of mock-treated controls using RT-qPCR probes that require transcription of ~150 nts or 
longer from the uaRNA TSS. Spliced mRNA levels were unchanged suggesting stable 
transcripts over this time course. We next determined uaRNA decay rates using flavopiridol 
treatment over a 1 hour time course (Figure 4B). Half-lives of 27, 19, 14, and 13 minutes were 
estimated for uaRNAs from Isg20l1, Tcea1, Txn1, and Sf3b1, respectively (Figure S7). 
The large decrease in uaRNA levels following loss of CDK9 activity supports P-TEFb 
dependent release from paused polymerase and bidirectional recruitment of P-TEFb at CpG 
island promoters. To confirm P-TEFb-dependent transcription, RNA produced from divergent 
TSSs for all four genes was measured following removal of flavopiridol. The uaRNAs (Figure 
4C, left panel) and nascent mRNA transcripts (Figure 4C, right panel) recovered with similar 
kinetics and reached control steady-state levels by 30 minutes after flavopiridol removal. The 
similar recovery rates at both TSSs further supports P-TEFb acting on both divergent RNA 
polymerases to promote elongation. 
 
Transcriptional induction of Isg20l1 similarly increases mRNA and uaRNA levels 
 Interferon-stimulated 20 kDa exonuclease-like 1, Isg20l1, is one of two homologs of an 
apoptosis-enhancing exonuclease. To determine how divergent paused RNAPII complexes 
respond to gene activation, doxorubicin, a DNA intercalator and inducer of double stranded 
breaks (Nitiss, 2009), was used to induce apoptosis in mESCs. Treatment with 1µM doxorubicin 
for 1.5, 4, and 6 hours was followed by measurement of Isg20l1 uaRNA, nascent mRNA, and 
spliced mRNA levels. Isg20l1 transcriptional output in either direction did not significantly 
change with 1.5 hours of treatment. However, both uaRNA and spliced mRNA transcripts had 
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equivalent induction levels of 8 and 12-fold following 4 and 6 hour treatments, respectively 
(Figure 5). The nascent mRNA transcripts showed only a 2-fold increase at 6 hours of treatment 
indicating tightly coordinated pre-mRNA processing. Divergent TSS products for thioreductase 
1, Txn1, which are not expected to respond to DNA damage, did not change with treatment and 
served as an additional control for transcription fidelity during cellular stress. These results 
support a model for gene activation at divergent CpG island promoters proceeded by stimulation 
of elongation in both directions.  
 
Discussion 
 The detection of capped 5ʹ′ termini on uaRNAs for all 4 studied promoters strongly 
supports a distinct and specific initiation event from antisense RNAPII complexes at divergent 
promoters. Further, RNAPII-Ser5P, NELF, and DSIF profiles at divergent TSSs suggest that 
these antisense RNAPII complexes are poised for transcription elongation. Correspondingly, we 
find that depletion of NELF and DSIF, factors known to promote the pausing of RNAPII, 
modestly increases steady-state uaRNA levels. This is consistent with the model that the two 
divergent and paused complexes are composed of similar factors controlling initial progression 
into elongation. In addition, we demonstrate that inhibition of P-TEFb activity with flavopiridol 
decreases both uaRNA and nascent mRNA transcript levels. P-TEFb phosphorylates the 
RNAPII-CTD, DSIF and NELF promoting elongation and its inhibition blocks elongation 
(Peterlin and Price, 2006). Since uaRNAs are short-lived, yet detectable in total RNA, upstream 
antisense RNAPII must be released from the paused state with kinetics comparable to their half-
lives. 
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  That RNAPII complexes are poised or stalled in the sense and antisense direction begs 
the question of how this process contributes to the local chromatin structure and overall gene 
activity.  In Drosophila cells, roughly two-thirds of all changes in gene expression upon NELF 
depletion were downregulation likely due to loss of RNAPII pausing that allows nucleosome 
assembly at the promoter (Gilchrist et al.; Gilchrist et al., 2008). However, one-third of all 
changes in gene expression were increases in transcript levels upon NELF depletion. We 
observed an increase in uaRNA and nascent mRNA levels upon NELF depletion. It could be that 
the mechanism and function of RNAPII pausing at our four divergent promoters are similar to 
the latter class described above. For example, mammalian promoters are frequently CpG-rich, 
and this tends to destabilize nucleosomes promoting nucleosome-free regions at the 5’-end of 
genes. Therefore, the impact of RNAPII pausing mechanisms to occlude nucleosome assembly 
may not be significant at divergently transcribed CpG-rich promoters.   
  Activation of the Isg20l1 divergent promoter upon doxorubicin treatment yielded 
simultaneous induction of transcription with similar levels and kinetics of spliced mRNA and 
uaRNA. These results were compelling as it illustrates the requirement for additional regulatory 
steps post P-TEFb recruitment to differentiate the sense and antisense RNAPII complexes for 
production of stable transcripts. In the sense direction, signals for continued productive 
elongation could involve the recruitment of P-TEFb-type activities by elongation complexes 
and/or pre-mRNA processing machinery and maintenance of Ser-2P. For example, P-TEFb has 
been shown to interact with the SR proteins involved in the recognition of exonic sequences (Lin 
et al., 2008). These signals may not be present in the antisense direction.  
Antisense transcription from divergent promoters produce uaRNAs that range from 1-4 
copies/cell with relatively short half-lives. Since the uaRNAs are 10-fold more abundant than the 
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20-25 nt antisense TSSa-RNAs, the latter are likely derived during the synthesis or processing of 
longer uaRNA through the endonucleolytic cleavage activities of the Transcription Factor II S 
(TFIIS) (Nechaev et al.) or the RNA exosome, respectively (Lebreton et al., 2008).  
 The mapping of uaRNA 3ʹ′ ends revealed heterogeneous populations possibly arising 
from nascent transcripts, or RNAPII termination, processing and/or degradation by the exosome. 
Analysis using 3'-RACE Southern blots on control and exosome depleted cells revealed that 
uaRNA 3' termini are distinct and longer in exosome-depleted cells. The 2-4 fold increase in 
uaRNA levels upon exosome depletion is modest but certainly in line with a previous study 
(Preker et al., 2008) that reports an average 1.5 fold increase in RNA originating 1kb upstream of 
known TSS. This increase is consistent with a dynamic and rapid turnover of antisense 
transcripts.  
Both the act of divergent transcription and the rapidly cycling promoter associated RNA 
could have multiple functions. In addition to possibly maintaining chromatin structure at 
promoter regions, it is possible that the nascent RNA tethered to RNAPII and/or disengaged 
could participate in regulation of local chromatin structure. For example, nascent RNAs 
transcriptionally engaged upstream of the cyclin D1 gene are thought to recruit TLS, a RNA 
binding transcriptional regulatory factor sensitive to DNA damage (Wang et al., 2008). In 
contrast, disengaged short sense RNAs found at the 5ʹ′ ends of Polycomb target genes have been 
reported to form stem-loop structures, which can bind Suz12 to promote silencing of the gene. 
(Kanhere et al., 2010). These two examples, among many others, suggest that uaRNAs could be 
involved in control of gene expression. 
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Methods 
Cell Culture Conditions 
V6.5 (C57BL/6-129) mouse embryonic stem cells (mESCs) (Koch Institute Transgenic Facility) 
were grown under standard ES cell culture conditions (Boyer et al., 2006).  
 
Lentiviral infection and total RNA preparation 
The shRNA targeting plasmids for knockdown of mRNA and empty plasmid (control) were 
ordered from Open Biosystems/Thermo Scientific (Huntsville, AL) (Table 1). For Lentivirus 
production, 293T cells were plated in 6-well dishes at 6x105 cells/well. Forty-eight hours after 
co-transfection of viral and shRNA plasmids into 293T cells, lentivirus was harvested and used 
directly to infect mESCs in a 6-well plate at 2x105 cells/well. The infection media was 1:2, viral 
media: mESC media with 2mM polybrene. Infected mESCs were then selected for 24 hours with 
2µM puromycin. Total RNA was collected using the RiboPure Kit (Ambion/Applied 
Biosystems; Austin, TX) according to the manufacturer’s protocol. 
 
RT-qPCR of RNA transcripts 
To assess mRNA knockdown and for other PCR analysis, complementary DNA (cDNA) was 
generated using the QuantiTect Reverse Transcription Kit (Qiagen; Velencia, CA) according to 
the manufacturer’s protocol with the following modification: a 5 minute genomic DNA (gDNA) 
elimination step. TaqMan gene expression assays (Applied Biosystems; Carlsbad, CA) were 
used to determine levels of mRNA transcripts after shRNA knockdown (Figure S8, Table 1). The 
ABI 7500 Real-Time PCR System was used with the accompanying software to analyze 
quantitative PCR (qPCR) data.  
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All other qPCR experiments were performed with Power SYBR Green PCR Master Mix 
(Applied Biosystems; Carlsbad, CA). Primers to detect uaRNAs, promoter RNAs, spliced 
mRNA (exon 1-2 junction, probe), and nascent mRNA (exon1-intron1, probe) are shown in 
Figure S9, Table 2A. Analysis of relative transcript levels was calculated using the delta-delta Ct 
method (Livak and Schmittgen, 2001). Once internal controls of β-Actin, GAPDH, and 28S 
rRNA were shown to be comparable standards, β-Actin was chosen as the internal control for all 
experiments. Error between biological replicates was calculated using a Standard Error of the 
Mean. Statistical significance was determined using a two-tailed, paired T-Test. P-values of < 
0.05 were reported for all RT-qPCR analysis 
 
For absolute quantitation, ssDNA Ultramer Oligonucleotides (IDT) were designed (Figure S10, 
Table 3) to contain the 5’-end of uaRNA transcripts. Standard curves were generated using their 
respective uaRNA qPCR primers. mESCs were collected, counted using a Coulter Counter 
(Millipore), and total RNA was prepared to determine average RNA concentration per mESC. A 
quantified number of cells were then subjected to qPCR using the uaRNA primer pairs and 
resulting qPCR signal was converted to copy number based on the ssDNA molar equivalents. 
 
Rapid Amplification of 5ʹ′  complementary DNA ends (5ʹ′-RACE) 
Total RNA was prepared using the standard Qiazol (Qiagen) protocol. Total RNA (10µg) was 
DNase treated with the Turbo DNA-Free kit (Ambion). Figure S9, Table 2B contains primers 
used for 5ʹ′-RACE with the FirstChoice RLM-RACE Kit (Ambion) with the following 
modifications. First, T4 RNA Ligase 1 (ssRNA Ligase) was heat-inactivated for 15 minutes at 
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65°C. Second, SuperScript III (SSIII, Invitrogen) was used for cDNA synthesis according to the 
manufacturer’s protocol. Reverse transcription was performed with a target specific primer, 
gsp1, at a 0.25µM final concentration. In addition, two subsequent nested PCR reactions using 
HotStarTaq (Qiagen) was performed with two forward primers, Po and Pi, 5ʹ′-RACE adaptor-
specific primers (Ambion), and two reverse target-specific primers, gsp-2 and gsp-3, at a 0.4µM 
final concentration (Figure S9, Table 2B). PCR 1 and PCR 2 were amplified for 20 and 25 to 30 
cycles, respectively. PCR reaction products were run on a 2% agarose gel, extracted using a 
QIAquick Gel Extraction Kit (Qiagen), and sequenced using Sanger methods. 
 
Rapid Amplification of 3ʹ′-complementary DNA ends (3ʹ′-RACE) 
Large (> 200 nts) RNA was prepared using the mirVana miRNA Isolation Kit (Ambion). Large 
fractionated RNA (5µg) was DNase-treated with the Turbo DNA-Free Kit (Ambion). The 
ligation reaction was performed with a 3ʹ′-RACE adaptor, synthesized with a 5ʹ′-phosphate and a 
3ʹ′-dideoxy-C (IDT) and used at a final 50µM concentration for 3ʹ′ end ligation. All primers for 
3ʹ′-RACE are listed in Figure S9, Table 2C. Reverse transcription was modified in the following 
manner: the SSIII protocol for GC-Rich templates was used in place of the standard and reverse 
transcription was performed with an adaptor-specific primer, 3ʹ′-RACE Po, at 0.25µM final 
concentration. Two subsequent PCR reactions were performed similarly as 5ʹ′-RACE, but instead 
with two forward target-specific primers, gsp-1 and gsp-2, and two reverse adaptor-specific 
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Flavopiridol and doxorubicin treatment of mECSs 
Flavopiridol (Sigma) and doxorubicin (Sigma) were resuspended to a final concentration of 
10mM in DMSO and stored at -80°C until used. Flavopiridol was added directly to the mESC 
culture media to a final concentration of 1µM and allowed to incubate for 1, 5, 10, 15, 30, and 60 
minutes in a tissue culture incubator at 37°C. For the wash-off experiments, flavopiridol treated 
mESCs were washed once with 37°C 1x Phosphate Buffered Saline. Fresh mESC media was 
added to the flavopiridol treated mESCs and they were placed at 37°C for 30, 60, or 90 minutes 
before total RNA was isolated as described above. Doxorubicin was added directly to the mESC 
culture media to a final concentration of 1µM and incubated for 1.5, 4 or 6 hours at 37°C. After 
the specified time, RNA was isolated as previously described and RT-qPCR was preformed to 
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Figure 1. Capped antisense RNA from divergent transcription initiate upstream of 
antisense TSSa-RNAs and display 3ʹ′  heterogeneity.  
UCSC Genome browser view showing the location of detected 5ʹ′ and 3ʹ′ ends using Rapid 
Amplification of cDNA Ends (RACE) at four selected CpG island divergent promoter genes: 
Isg20l1, Tcea1, Txn1, and Sf3b1. 5ʹ′-RACE analysis was performed on upstream regions 
containing more than one overlapping antisense TSSa-RNA (Seila et al., 2008). Promoter 
regions are shown with the TSSs marked (arrows pointing in the direction of transcription). 
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with arrows pointing to the right. Sense TSSs (right arrows) were labeled according to UCSC 
genome browser's known genes from UniProt, RefSeq, and GenBank. These were independently 
confirmed by 5ʹ′-RACE for Isg20l1, Tcea1, and Txn1. 3ʹ′-RACE analysis yielded various uaRNA 
transcripts (green) for each divergent promoter. These range in length from approximately 50 nts 
to 1100 nts. ChIP-seq binding profiles of RNAPII, H3K4me3, H3K79me2, TATA-binding 
protein (TBP), TSSa-RNA reads (antisense = blue; sense = red), and CpG island regions (green) 
are shown. ChIP-Seq data was obtained from the following published reports: RNAPII-8W16 
(6), H3K4me3 and H3K79me2 (23), and TBP (22). We note the absense of a sense RNAPII 
ChIP-seq peak at the annotated TSS of Tcea1, likely explained in part to difficulties in mapping 
reads to this region since it contains high similarity (99%) with a location on chromosome 15. 
































Figure 2. uaRNA transcripts are substrates for the exosome. 
A. Relative levels of uaRNA (grey amplicon in Figure S2A, dark gray) and spliced mRNA 
(exon1-2 probe, light gray) transcripts in mESCs infected with virus containing an shRNA 
targeting Exosc5 (shExosc5) and assayed by RT-qPCR (probes shown in Figure S9, Table 2A). 
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(pLKO.1), and normalized to β-actin levels. Values represent four biological replicates and error 
represents the respective SEM. Asterisks represent significance of p < 0.05 in two-sided T-test. 
B. 3ʹ′-RACE followed by Southern blot analysis of control and shExosc5 treated mESC RNA. 
The Southern blots were probed with probe 1 shown in Figure S6. Minus RT lanes refer to 3ʹ′-
RACE experiments with no reverse transcriptase added in the RT step of the procedure. 
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Figure 3 
 
                 
 
 
Figure 3. Pausing factors at the antisense RNAPII complex regulate uaRNA levels.  
A. UCSC Genome browser views of the four divergent promoter regions displaying ChIP-seq 
binding profiles (13) of RNAPII-Ser5P, Supt5h, NELF-A, and the full length antisense RNA 
transcripts. Each region diagrammed spans 2kb and scale bars represent 500 bp. B. Relative gene 
expression of Nelf-A, Nelf-E, and Supt4h in control and shRNA knockdown mESC after 48 
hours of selection measured by Taqman RT-qPCR assay. Values represent six biological 
replicates and error represents the respective SEM. C. Transcript changes in shNELF-A, 
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levels are represented by blue and red bars, respectively (probes shown in Figure S9, Table 2A). 
Values represent six biological replicates and error shows the respective SEM. Asterisks 
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A. Relative levels of spliced mRNA (red), nascent RNA (exon1-intron1 probe, green), and 
uaRNA (blue) transcripts, as measured by RT-qPCR, after a 1µM flavopiridol treatment for 1 
hour. B. uaRNA transcript levels assayed by RT-qPCR from amplicon shown in Figure S2A over 
a 1 hour time course with 1µM flavopiridol. C. uaRNA (left panel) and nascent sense RNA (right 
panel) levels assayed by RT-qPCR over an hour 1µM flavopiridol treatment followed by a 
Phosphate Buffered Saline (PBS) wash off of flavopiridol at the indicated times. Isg20l1, Tcea1, 
Txn1, and Sf3b1 RNA transcripts are shown in blue, red, green, and purple, respectively. All 
values are relative to mock (DMSO) treated cells and normalized to β-Actin. Values represent 
two biological replicates with the error representing the respective SEMs. All probe sequences 
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Figure 5 
        
 
 




Figure 5. Divergent sense and antisense transcription induced with similar kinetics. 
mESCs were treated with 1µM doxorubicin for 1.5, 4, and 6 hours after which total RNA was 
collected. RT-qPCR analysis to determine the relative fold change of nascent, spliced mRNA, 
and uaRNA transcription followed. Changes in transcript levels for two genes, Isg20l1 and Txn1, 
green and blue bars, respectively are shown. Values represent biological triplicates and error of 
the respective SEM. All probes are shown in Figure S9, Table 2 
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Table S1 
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Table S2 
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Table S3 
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Figure S1 
 
            
            
 
 
Figure S1.  uaRNAs contain a cap structure at the 5ʹ′  termini. 
All PCR products were collected from the gel, cloned into a TOPO vector, and transformed into 
competent cells. Five colonies for each band were selected for sequencing. From these 
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the CIP+TAP+ lane. Despite appearances of similarly sized bands in the CIP+TAP+ and CIP-
TAP- lanes, these products did not contain sequences from the promoter regions. For Tcea1, the 
addition of CIP prior to TAP treatment allowed for the detection of an additional antisense 5ʹ′ end 
cap site likely explained by the increase in PCR efficiency upon removal of uncapped 
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Figure S2 
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A. UCSC Genome browser view showing the location of detected antisense TSSs using Rapid 
Amplification of 5ʹ′ cDNA Ends (5ʹ′-RACE) at four selected CpG island promoter genes: Isg20l1, 
Tcea1, Txn1, and Sf3b1 (Figure 1, Figure S1). Arrows depicting antisense transcription are 
pointing to the left while sense TSSs are marked with arrows pointing to the right. Tracks: 
RNAPII ChIP-seq profiles in mESCs (black), qPCR amplicon (gray), antisense (blue) and sense 
(red) TSSa-RNAs, and CpG island (green). Each genomic region displayed spans 2kb and the 
scale bar represents 500 bp. B. Absolute quantification of the upstream antisense RNAs 
(uaRNAs) determined by qPCR using a ssDNA oligonucleotide standard. The values represent 
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Figure S3. Strand-specific RT-qPCR on RNAs that originate in the upstream antisense or 
promoter regions.  
Promoter regions are diagrammed for Isg20l1, Tcea1, Txn1, and Sf3b1, respectively. Sense TSSs 
are noted with a right facing arrow and set to position zero. Upstream antisense TSSs are noted 
with a left facing arrow. All uaRNA identified are represented by red bars and the first 300 nts of 
each sense transcript is shown as green bars. Amplicons for the “upstream” and “promoter” 
qPCR primers (Figure S9, Table 2) are shown for each gene as orange and yellow bars, 
respectively. Absolute quantitation was used to calculate copy number from strand-specific RT-
qPCR reactions and copy numbers appear in the table below each sense TSS. The (-) and (+) 
strand columns represent transcripts amplified from either the “-” or “+” strand using a strand-
specific RT primer, while the rows “upstream” and “promoter” correspond to the primer pair 
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Figure S4 
 
     
 
 
Figure S4. 3ʹ′-RACE products are reverse-transcriptase dependant. 
A. 3ʹ′-RACE products were separated on a 2% agarose gel and the specific bands that were 
cloned and sequenced are marked with an asterisk (*) and shown in the UCSC Genome Browser 
in Figure 1. The above gels are examples that yielded uaRNA sequences shown in Figure 1. 
Samples displaying –RT did not receive were reverse transcriptase during cDNA synthesis. Size 





































































        
            
 
 
Figure 5. shRNA-mediated Exosc5 knockdown in V6.5 ES cells. 
Relative gene expression of Exosc5, component of the exosome, as determined by RT-qPCR 
using Taqman probes (Figure S8, Table 1). Percent mRNA levels are shown compared to mock 
knockdown RNA samples. Values represent biological triplicates and error bars represent SEM 
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Figure S6. uaRNAs have 3ʹ′  heterogeneity and their lengths are altered upon exosome 
depletion. 
A. Genome browser views of the four divergent promoter regions displaying ChIP-Seq signal for 
RNAPII, the mapped uaRNA transcripts, and the southern blot probes used in Figure 2B and 
Figure S6B. For each region, two probes were designed to be either proximal (probe 1) or distal 
(probe 2) to the antisense TSS. B. 3ʹ′-RACE followed by Southern blot analysis from either 
control (pLKO.1) or knockdown (shExosc5) mESCs. For each uaRNA region, both probes 
described above were used to visualize the RNA species. A range of PCR cycles was used during 
the 3ʹ′-RACE protocol to assay the most abundant transcripts as determined by the detection of 
the initial products. The number of cycles used for control and knockdown samples are indicated 























     




Figure S7. uaRNA half-life calculations. 
 Scatter plot of the relative uaRNA transcript abundances over a one hour flavopiridol treatment. 
For each gene, a best fit logarithmic curve was determined and equations corresponding to each 
gene are shown in the upper right-hand corner. Using the equations found in part A, half-lives 









T½ - Isg20l1 = 27.28 minutes
T½ - Tcea1 = 19.36 minutes 
T½ - Txn1 = 13.85 minutes
T½ - Sf3b1 = 12.89 minutes
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Abstract 
Transcription of the mammalian genome is pervasive but productive transcription outside 
protein-coding genes is limited by unknown mechanisms (Djebali et al., 2012). In particular, 
although RNA polymerase II (RNAPII) initiates divergently from most active gene promoters, 
productive elongation occurs primarily in the sense coding direction (Core et al., 2008; Preker et 
al., 2008; Seila et al., 2008). Here we show that asymmetric sequence determinants flanking gene 
transcription start sites (TSS) control promoter directionality by regulating promoter-proximal 
cleavage and polyadenylation. We find that upstream antisense RNAs (uaRNAs) are cleaved and 
polyadenylated at poly (A) sites (PAS) shortly after their initiation. De novo motif analysis 
reveals PAS signals and U1 snRNP (U1) recognition sites as the most depleted and enriched 
sequences, respectively, in the sense direction relative to the upstream antisense direction. These 
U1 and PAS sites are progressively gained and lost, respectively, at the 5’ end of coding genes 
during vertebrate evolution. Functional disruption of U1 snRNP activity results in a significant 
increase in promoter-proximal cleavage events in the sense direction with slight increases in the 
antisense direction. These data suggests that a U1-PAS axis characterized by low U1 recognition 
and high density of PAS in the upstream antisense region reinforces promoter directionality by 
promoting early termination in upstream antisense regions whereas proximal sense PAS signals 
are suppressed by U1 snRNP. We propose that the U1-PAS axis limits pervasive transcription 
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Introduction 
 Two potential mechanisms for suppressing transcription elongation in the upstream 
antisense region of gene TSS include inefficient release of paused RNAPII and / or early 
termination of transcription. RNAPII pauses shortly after initiation downstream of the gene TSS 
and the paused state is released by the recruitment and activity of p-TEFb (Adelman and Lis, 
2012). A detailed characterization of several uaRNAs in mouse embryonic stem cells (mESCs) 
suggested that p-TEFb is recruited similarly in both sense and antisense directions (Flynn et al., 
2011), and in human cells, elongating RNAPII (phosphorylated at serine 2 in the C-terminal 
domain) occupies the proximal upstream transcribed region (Preker et al., 2011). These data 
argue that the upstream antisense RNAPII complex undergoes the initial phase of elongation but 
likely terminates early due to an unknown mechanism.  
 
Results 
To test globally whether upstream antisense transcripts undergo early termination 
(compared to coding mRNA) by a canonical PAS-dependent cleavage mechanism, we mapped 
by deep sequencing the 3’-ends of polyadenylated RNAs in mESCs. For most protein-coding 
genes, transcription termination is triggered by cleavage of the nascent RNA upon recognition of 
a PAS whose most essential feature is an AAUAAA sequence or a close variant located about 
10-30 nucleotides upstream of the cleavage site (Proudfoot, 2011). We sequenced two cDNA 
libraries and obtained over 230 million reads, of which 114 million mapped uniquely to the 
genome with at most two mismatches. We developed a computational pipeline to identify 
835,942 unique 3’-ends (cleavage sites) whose poly (A) tails are likely to be added post-
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transcriptionally and are also associated with the canonical PAS hexamer or its common variants 
(Supplementary Fig. 1, see Methods).  
To investigate whether uaRNAs are terminated by PAS-dependent mechanisms, we 
focused our analysis on cleavage sites proximal to gene TSS and at least 5 kilobases (kb) away 
from known gene transcription end sites (TES). Interestingly, in the upstream antisense region 
we observed a 2-fold higher number of cleavage sites compared to the downstream sense sites 
flanking protein-coding gene TSS (Fig. 1a). The peak of the upstream antisense cleavage sites is 
about 700 bases from the coding gene TSS. This observation suggests that upstream antisense 
transcripts are frequently terminated by PAS-directed cleavage shortly after initiation, a trend we 
also observe in various tissues of mouse and human (Derti et al., 2012) (Supplementary Fig. 2). 
Inspection of gene tracks at the Pigt locus reveals upstream antisense cleavage shortly after a 
PAS (AATAAA) less than 400 bases from the Pigt TSS, whereas in the sense direction cleavage 
is confined to the TES (Fig. 1b). Similar patterns were observed for subsets of promoters 
(promoters without nearby genes, Global Run-On Sequencing (GRO-seq) defined divergent 
promoters, and Chromatin immunoprecipitation sequencing (ChIP-seq) defined RNAPII-
occupied promoters (Rahl et al., 2010), or for high confidence cleavage sites, cleavage reads, and 
cleavage clusters (Supplementary Fig. 3). Of all divergent promoters, nearly half (48%) produce 
PAS-dependent upstream antisense cleavage events within 5 kb of coding gene TSS, compared 
to 33% downstream of the TSS. We validated several of these promoter proximal sense and 
antisense cleavage sites using Rapid Amplification of 3’ cDNA ends (3’-RACE) (Supplementary 
Fig. 4).  
Similar to annotated cleavage sites at TES of genes, these upstream antisense cleavage 
sites are associated with the PAS located at the expected position, about 22 nucleotides upstream 
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the cleavage site (Supplementary Fig. 5a-b). Moreover, the nucleotide sequence composition 
flanking the cleavage sites resembles that of TES of genes (Supplementary Fig. 5c-e) including a 
downstream U-rich region (Gil and Proudfoot, 1987; MacDonald et al., 1994). To determine 
whether members of the canonical cleavage and polyadenylation machinery bind specifically to 
uaRNA cleavage sites, we analyzed available cross-linking immunoprecipitation (CLIP) 
sequencing datasets for 10 canonical 3’ end processing factors, including CPSF-160, CPSF-100, 
CPSF-73, CPSF-30, Fip1, CstF-64, CstF-64τ, CF Im25, CF Im59, and CF Im68 along with poly 
(A) 3’-end sequencing data generated in HEK293 cells (Martin et al., 2012). We detect specific 
binding of all 10 factors at uaRNA cleavage sites with positional profiles identical or very 
similar to that of mRNA cleavage sites (Supplementary Fig. 6). These results indicate the poly 
(A) tails that we analyzed are products of PAS-dependent cleavage and polyadenylation, rather 
than either a priming artifact or PAS-independent polyadenylation representing a transient signal 
for RNA degradation (LaCava et al., 2005; Vanacova et al., 2005; Wyers et al., 2005).  
As a first step to understand the molecular mechanism underlying the cleavage bias, we 
examined the frequency of PAS in a 6 kb region on the four strands flanking the coding gene 
TSS. We observed an approximately 33% depletion of the canonical AATAAA PAS hexamer 
specifically downstream of the TSS on the coding strand of genes as compared to the other 
regions (Fig. 2a). Since this 33% depletion is unlikely to explain the 2-fold cleavage bias 
observed (see simulation results in Supplementary Fig. 8a), we searched for additional 
discriminative 6-mer sequence signals in an unbiased manner. All 4096 hexamers were ranked 
by enrichment in the first 1 kb of the sense strand of genes relative to the corresponding 
upstream antisense region (Fig. 2b). Interestingly, we identified the PAS as the most depleted 
sequence in sense genes relative to the upstream antisense region of gene TSS. In addition, we 
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identified 5’ splice site related sequences (or sequences recognized by U1 referred to as U1 sites) 
as the most enriched hexamers in sense genes (Fig. 2b) relative to antisense regions. This 
includes the consensus GGUAAG (first) that is perfectly complementary to the 5’ end of the U1 
snRNA, as well as GGUGAG (third) and GUGAGU (fifth), which represent common 5’ splice 
site sequences (with the first GU in each motif located at the intron start). Consistent with the 
hexamer enrichment analysis, a metagene plot displaying an unbiased prediction of strong, 
medium, and weak U1 sites (see Methods) revealed strong enrichment of U1 signals in the first 
500 bps downstream of the TSS, with essentially only background levels observed in all other 
regions and a small depletion in the upstream antisense direction (Fig. 2c). 
The asymmetric distribution of U1 sites and PAS sites flanking the TSS could potentially 
explain the biased cleavage pattern shown in Fig. 1a if the U1 complex suppresses cleavage and 
polyadenylation near a U1 site, as has been observed in various species including human and 
mouse (Andersen et al., 2012; Berg et al., 2012; Kaida et al., 2010). Consistent with this model, 
we observed a depletion of cleavage sites, especially frequent cleavage sites, downstream of 
strong U1 sites (Supplementary Fig. 7a). Focusing on the upstream antisense direction, the 
presence of proximal PAS sites (within 1 kb of coding gene TSS) is significantly associated with 
shorter uaRNAs (p < 1e-15), whereas the presence of proximal U1 sites is significantly 
associated with longer uaRNAs but only in the presence of proximal PAS sites (p < 0.0006), 
consistent with a model where U1 promotes RNA lengthening by suppressing proximal PAS 
(Supplementary Fig. 7b). To test whether the encoded bias in U1 and PAS signal distribution 
explains the cleavage bias observed from our 3’-end sequencing analysis, we performed a 
cleavage site simulation using predicted strong U1 sites and canonical PAS (AATAAA) 
sequences. Specifically, we defined a protection zone of 1 kb downstream of a strong U1 site and 
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used the first unprotected PAS as the cleavage site. The metagene plot of simulated cleavage 
events (Fig. 2d) recapitulate the major features of the observed distribution (Fig. 1a), including 
an antisense peak around 700 bases upstream and a ~2-fold difference between sense and 
antisense strands. Similar patterns were robustly observed when varying the size of the 
protection zone (Supplementary Fig. 8). Thus, we identified a U1-PAS axis flanking gene 
promoters that may explain why uaRNAs undergo early termination.   
To validate the U1-PAS axis model, we functionally inhibited U1 in mESCs. 
Specifically, we transfected mESCs with either an antisense morpholino oligonucleotide (AMO) 
complementary to the 5’ end of U1 snRNA to block its binding to 5’ splice sites (or similar 
sequences) or a control AMO with scrambled sequences followed by 3’-end RNA sequencing 
(Berg et al., 2012; Kaida et al., 2010). Interestingly, we observe in two biological replicates a 
dramatic increase in promoter-proximal cleavage events in coding genes but only a slight 
increase in upstream antisense regions, which eliminates the asymmetric bias in promoter-
proximal cleavage we observed in either the wild-type cells or cells treated with scrambled 
control AMOs (Fig. 3). These observations confirm that U1 protects sense RNA in protein-
coding genes from premature cleavage and polyadenylation in promoter proximal regions, thus, 
reinforcing transcriptional directionality of genes. However, in the antisense direction, the 
activity of U1 is much less and there is little enhancement in cleavage sites upon inhibition of U1 
recognition.  
The conservation of the asymmetric cleavage pattern across human and mouse 
(Supplementary Fig. 2) led us to examine if there is evolutionary selection on the U1-PAS axis. 
Previously, mouse protein-coding genes have been assigned to 12 evolutionary branches and 
dated by analyzing the presence or absence of orthologs in the vertebrate phylogeny (Zhang et 
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al., 2010). We find strong trends of progressive gain of U1 sites depending on the age of a gene 
(Fig. 4a) and loss of PAS sites (Fig. 4b) over time at the 5’ end (the first 1 kb) of protein-coding 
genes, suggesting that suppression of promoter-proximal transcription termination is important 
for maintaining gene function. Interestingly, the same trends, although weaker, are observed in 
upstream antisense regions, suggesting at least a subset of uaRNAs may be functionally 
important in that over time they gain U1 sites and lose PAS sites to become more extensively 
transcribed. In addition to the coding strand of genes (downstream sense region), PAS sites were 
also progressively lost on the other three strands flanking TSS (Fig. 4b). This observation 
probably reflects on the increases in CpG-rich sequences within 1 kb of gene TSS and suggests 
that coding genes acquire CpG islands as they age (Fig. 4c). However, the bias of low PAS site 
density in the sense direction extends across the total transcription unit (Supplementary Fig. 9) 
and is distinct from the CpG density near the promoter.  
We also propose that some long noncoding RNAs (lncRNAs) generated from 
bidirectional promoters might represent an evolutionary intermediate between uaRNAs and 
protein-coding genes. Consistent with this, annotated head-to-head mRNA-lncRNA pairs as a 
whole showed a bias (in terms of promoter-proximal cleavage site, U1 site, and PAS site 
distributions flanking coding gene TSS) weaker than head-to-head mRNA-uaRNA pairs but 
stronger than mRNA-mRNA pairs (Supplementary Fig. 10). This is also consistent with recent 
results suggesting that de novo protein-coding genes originate from lncRNAs at bidirectional 
promoters (Xie et al., 2012).  
The U1-PAS axis likely has a broader role in limiting pervasive transcription throughout 
the genome. The enrichment of U1 sites and depletion of PAS sites are confined to the sense 
strand within the gene body, whereas intergenic and antisense regions show relatively high PAS 
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but low U1 density (Supplementary Fig. 9), indicating the U1-PAS axis may serve as a 
mechanism for terminating transcription in both antisense and intergenic regions.  
 
Discussion 
Together, we propose that a U1-PAS axis is important in defining the directionality for 
transcription elongation at divergent promoters (Supplementary Fig. 11). Although the U1-PAS 
axis may explain the observed cleavage bias at promoters surprisingly well, it seems likely that 
additional cis-elements may influence PAS usage (Hu et al., 2005) and will need to be integrated 
into this model. There may also be other PAS-independent mechanisms that contribute to 
termination of transcription in upstream antisense regions and across the genome (Arigo et al., 
2006; Connelly and Manley, 1989; Zhang et al., 2013). However, evidence for the U1-PAS axis 
is found in several different tissues of mouse and human, indicating its wide utilization as a 
general mechanism to regulate transcription elongation in mammals. Like protein-coding 
transcripts, lncRNAs must also contend with the U1-PAS axis. These RNAs and short non-
coding RNAs from divergent transcription of gene promoters may be considered part of a 
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Methods 
Cell Cuture. V6.5 (C57BL/6-129) mouse embryonic stem cells (mESCs) (Koch Institute 
Transgenic Facility) were grown under standard ES cell culture conditions (Seila et al., 2008). 
 
Poly(A) 3’-End sequencing. Total RNA was extracted from V6.5 mESCs using Ambion’s 
Ribopure kit (AM1924M). Poly (A) selected RNA was fragmented using RNase T1 (AM2283). 
Reverse transcription was performed with an RT oligo (Table S1) at 0.25 uM final concentration 
using Invitrogen’s Superscript III Reverse Transcriptase (18080-44) according to the 
manufacturer’s protocol. The resulting cDNA was run on a 6% TBE-Urea polyacrylamide gel 
(National Diagnostics) and the 100-300 size range of products were gel extracted and eluted 
overnight. The gel-purified cDNA products were circularized using CircLigase II (CL9025K) 
according to the manufacturer’s protocol. Circularized cDNA was PCR-amplified using the 
Phusion High-Fidelity DNA Polymerase (MO530L) for 15-18 cycles using the primers described 
in Table S1. Amplified products were run on a 1.5 % agarose gel and the 200-400 size range was 
extracted using Qiagen’s MinElute Gel Extraction Kit (28604). The 3’-end library was then 
submitted for Illumina sequencing on the HI-Seq 2000 platform. 
 
U1 inhibition with antisense morpholino oligonucleotides (AMO). V6.5 mESCs were 
transfected using the Amaxa Nucleofector II with program A-23 (mESC-specific) according to 
the manufacturers protocol. Specifically, 2.5 million V6.5 mESCs were transfected with 7.5 uM 
of U1-targeting or a scrambled AMO for 8 hrs, (Berg et al., 2012; Kaida et al., 2010) prior to 
RNA sequencing analysis. 
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3’-RACE. Total RNA was extracted using Ambion’s Ribopure kit and DNase-treated using 
Ambion’s DNA Free-Turbo. 3’-RACE was performed using Ambion’s Gene Racer Kit 
according to the manufacturer’s instructions. 3’-end PCR products were run on a 1.5% agarose 
gel, gel extracted using Qiagen’s gel extraction kit, and Sanger sequenced. All primers are 
described in Table S1. 
 
Reads mapping. Raw reads were processed with the program cutadapt (Martin	  et	  al.,	  2011) to 
trim the adaptor sequence (TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCAC) 
from the 3’ end. Reads longer than 15 nts after adaptor trimming were mapped to the mouse 
genome (mm9) with bowtie31 requiring unique mapping with at most two mismatches (options: -
n 2 -m 1 --best --strata). Mapped reads were collapsed by unique 3’ end positions.  
 
Internal priming filter. To remove reads whose A-tail is encoded in the genome rather than 
added post-transcriptionally, we filtered reads that have 1) more than 10 As in the first 20 nt 
window or 2) more than 6 As in the first 10 nt window downstream from the detected cleavage 
site of the 3’-end. The threshold used is based on the bimodal distribution of the number of As 
downstream of annotated TES.  
 
PAS filter. In addition to a set of 12 hexamers identified previously in mouse and human EST 
analysis (Beaudoing et al., 2000; Tian et al., 2005), we analyzed the annotated TES in the mouse 
genome to identify additional potential PAS variants. All hexamers with at most two mismatches 
to the canonical AATAAA motif were used to search in the sequence up to 100 nts upstream of 
annotated TES. The distribution of the position of each hexamer relative to the TES (a 
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histogram) is compared to that of AATAAA. Hexamers with a position profile similar to 
AATAAA will have a peak around position 20-24. We quantified the similarity by Pearson 
correlation coefficient and used a cut-off of 0.5 after manual inspection. In total, 24 new 
hexamers were identified as potential PAS and a hierarchy was assigned for the 36 hexamers 
(PAS36): first, the 12 known variants are ranked by their frequency of usage in the mouse 
genome, and then the newly identified PAS ranked by their correlation with AATAAA in terms 
of the positional profile defined above. To define a window where most PAS or variants are 
located, we searched for each of the 36 PAS variants within 100 nts of annotated gene 3’ ends 
and chose the best one according to the designated hierarchy. We summarized the distance of the 
best PAS to the annotated TES and defined a window of (0-41) around the position 22 peak such 
that 80% of the annotated TES have their best-matched PAS within that window. Using these 
criteria, we searched for PAS36 variants within the 0-41 window upstream of our experimentally 
sequenced 3’-ends. If there were multiple PAS hexamers identified within this window for a 
given 3’-end, we chose the best one defined by the hierarchy described above. Reads without any 
of the 36 PAS variants within the 0-41 window were discarded.          
 
Remove potential false positive cleavage sites. Due to sequencing error, abundant transcripts 
such as ribosomal gene mRNAs can produce error-containing 3’ end reads that mapped to other 
locations in the genome, leading to false positive cleavage sites. To remove such potential false 
positive sites, we defined a set of 71674 (7.5%) abundant cleavage sites that are supported with 
more than 100 reads from the pooled library. A bowtie reference index was built using sequences 
within 50 nts upstream of those abundant sites. Non-abundant sites within these 50 nts reference 
regions were not used to search for false positives. Reads initially mapped to sites outside these 
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reference regions were re-mapped against the new index allowing up to two mismatches. Reads 
mapped to any of the reference regions in this analysis were treated as potential false positive 
reads. Cleavage sites containing only potential false positive reads are defined as potential false 
positive sites and were removed from subsequent analysis. In total, 7.2% (389185) of initially 
mapped reads are outside the reference regions. 0.34% of all mapped reads were classified as 
potential false positive reads and 9.1% (86425) of all cleavage sites were identified as potential 
false positive sites.       
 
Remove B2 SINE RNA associated cleavage sites. We further removed cleavage sites 
associated with B2_Mm1a and B2_Mm1t SINE RNAs. These B2 SINE RNAs are transcribed by 
RNA Pol III but contain AAUAAA sequences near the 3’ end. In total, 3.5% (33696) of all 
cleavage sites passing the internal priming filter and the PAS filter were mapped within B2 
regions or within 100 nts downstream of B2 3’ end. These sites were removed.  
 
Prediction of U1 sites / putative 5’ splice sites. A nucleotide frequency matrix of 5’ splice sites 
(3 nt in exon and 6 nt in intron) was compiled using all annotated constitutive 5’ splice sites in 
the mouse genome. The motif was then used by FIMO (Grant	  et	  al.,	  2011)to search significant 
matches (p<0.05) on both strands of the genome. Matches were then scored by a Maximum 
Entropy model (Yeo and Burge, 2004). Maximum entropy scores for all annotated 5’ splice sites 
were also calculated to define thresholds used to classify the predicted sites into strong, medium 
and weak. Sites with scores larger than the median of annotated 5’ splice sites (8.77) were 
classified as ‘strong’. Sites with scores lower than 8.77 but higher than the threshold dividing the 
first and second quarter of annotated 5’ splice sites (7.39) were classified as ‘medium’, and the 
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rest of the predicted sites with scores higher than 4 were classified as ‘weak’. Sites with scores 
lower than 4 were discarded.  
 
Define a set of divergent promoters. GRO-seq data from mESCs (Min et al., 2011) were used 
to define a set of active and divergent promoters. Active promoters were defined as promoters 
with GRO-seq signal detected within the first 1 kb downstream sense strand.  A promoter was 
considered divergent if it contained GRO-Seq signal in the first 1 kb downstream the sense 
strand and within the first 2 kb of the upstream antisense strand. A minimum number of two 
reads within the defined window (downstream 1 kb or upstream 2 kb) were used as a cut-off for 
background signals. 
 
Define RNAPII Ser5P bound TSS. ChIP-seq data for ser5p RNA Pol II and corresponding 
input was downloaded from GEO database (accession number GSE20530 (Rahl	  et	  al.,	  2010)) 
and peaks called using MACS (Zhang et al., 2008) with default settings. TSS less than 500bps 
away from a peak summit are defined as bound. 
 
Discriminative hexamer analysis. An unbiased exhaustive enumeration of all 4096 hexamers 
was performed to find hexamers that are discriminative of downstream sense and upstream 
antisense strands of protein-coding gene promoters. Specifically, the first 1000 nucleotides 
downstream sense and upstream antisense of all protein-coding gene TSS were extracted from 
repeat masked genome (from UCSC genome browser, non-masked genome sequence gave 
similar results). For each hexamer, the total number of occurrences on each side was counted and 
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then the log2 ratio of the occurrences on sense versus antisense strand was calculated as a 
measure of enrichment on the sense but depletion on the antisense strand.  
 
Cleavage site simulation. Protein-coding genes and 10 kb upstream antisense regions were 
scanned for strong U1 sites and PAS sites (AATAAA). Starting from protein coding gene TSS, 
the first unprotected PAS was predicted to be the cleavage site. A PAS is protected only if it is 
within a designated protection window (in nucleotides) downstream (+) of a strong U1 site.  
 
Binding of 3’ end processing factors in uaRNA regions. RNA 3’ end cleavage and 
polyadenylation sites and CLIP-seq read density of ten 3’ end processing factors in wild type 
HEK293 cells were downloaded from Gene Expression Omnibus (GEO) dataset GSE37401. A 
cleavage site is defined as a uaRNA cleavage site if it is outside any protein-coding gene but 
locates within 5 kb upstream antisense of a protein-coding gene. mRNA cleavage sites are 
defined as cleavage sites within 100 bases of annotated protein-coding gene ends. For each 3' 
end-processing factor, CLIP read density within 200 bases of all cleavage sites are added up 
every 5bp bin and then normalized such that the max value is 1. 
 
Evolutionary analysis of U1 sites, PAS sites, and CpG islands. Mouse protein-coding gene 
branch/age assignment was obtained from a previous analysis (Zhang et al., 2010). The number 
of strong U1 sites, PAS (AATAAA) sites, and CpG islands (UCSC mm9 annotations) in the first 
1 kb region flanking TSS on each strand were calculated, and the average number of sites in each 
branch/age group was plotted against gene age. Pearson correlation coefficient and linear 
regression fitting were done using R. Significance of the correlation was assessed by comparing 
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to a null distribution of correlation coefficients calculated by shuffling gene branch/age 
assignments 1000 times. 
 
Bidirectional promoter analysis. For each annotated TSS the closest upstream antisense TSS 
was identified and those TSS pairs within 1 kb were defined as head-to-head pairs. LncRNAs 
were defined as noncoding RNAs longer than 200 bps. UCSC mm9 gene annotations were used 
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Figure 1 
 
                     
Promoter-proximal PAS-dependent termination of uaRNA. a, Metagene plot of sense (red) 
or antisense (green) unique cleavage sites flanking coding gene TSS. The number of unique 
cleavage sites per gene per base in each 25 bp bin across 5 kb upstream and downstream of the 
TSS is plotted. Mean cleavage density of first 2 kb: sense/antisense = 1.45/3.10. b, Genome 
browser view from the PIGT locus (shown in black on the + strand) displaying the following 

















































	   109	  
tracks with + strand (top) and – strand (bottom) represented: GRO-Seq (purple)(Min et al., 
2011), Poly (A)+ RNA-Seq (blue) (Sigova et al., 2013), 3’end RNA-Seq (orange), and PAS 
(AAUAAA, black). For each gene track, the x-axis represents the linear sequence of genomic 
DNA. The numbers on the top left corner represent the maximum read density on each track.  
 
Figure 2 
         
Asymmetric distribution of PAS and U1 signals flanking coding gene TSS. a. Number of 
AATAAA sites per gene per base in each 25 bp bin within a 3 kb region flanking gene TSS on 
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the downstream sense (red), downstream antisense (light blue), upstream antisense (green), and 
upstream sense (dark blue) strands. b, Rank of all 4096 hexamers by enrichment (log2 ratio) in 
the first 1 kb of all coding genes in the sense direction relative to 1 kb in the upstream antisense 
direction of the TSS. c, Density of predicted 5’ splice sites within a 1 kb region flanking gene 
TSS. Strong, medium, and weak 5’ splice sites are defined in Methods. d, Metagene plot of 
simulated cleavage sites around gene TSS. The first unprotected PAS (AAUAAA) that is not 
within 1 kb downstream of a strong U1 site for all coding genes is plotted. Mean cleavage 
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Figure 3 
                
Promoter-proximal cleavage sites are altered upon functional U1 inhibition. 
Y-axis is the number of cleavage sites per gene per base divided by the total number of cleavage 
sites identified in each 3’ end-sequencing library in a 5 kb region flanking coding gene TSS. 
Signal for the antisense strand is set as negative. U1 inhibition 1 (purple) and U1 inhibition 2 
(blue) represent 3’-end sequencing libraries generated from mESCs treated with a U1-targeting 
AMO. Control 1 (red) and Control 2 (orange) represent 3’-end sequencing libraries generated 
from mESCs treated with a scrambled control AMO. Mean	  cleavage	  density	  of	  first	  2	  kb:	  sense/antisense	  =	  2.5/4.4	  (Control	  1),	  2.4/4.3	  (Control	  2),	  7.0/5.8	  (U1	  inhibition	  1),	  5.9/5.5	  (U1	  inhibition	  2). 
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Figure	  4	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Evolutionary	  gain	  and	  loss	  of	  U1	  and	  PAS	  sites.	  a,	  Average	  number	  of	  strong	  U1	  sites	  in	  the	  first	  1	  kb	  of	  protein-­‐coding	  genes	  and	  upstream	  regions.	  b,	  Average	  number	  of	  PAS	  sites	  in	  the	  first	  1	  kb	  downstream	  and	  upstream	  of	  coding	  gene	  TSS,	  respectively.	  c,	  Average	  number	  of	  CpG	  islands	  overlapping	  the	  first	  1	  kb	  of	  protein-­‐coding	  genes	  and	  upstream	  regions.	  Genes	  are	  divided	  into	  12	  ordered	  groups	  by	  gene	  age.	  X-­‐axis	  indicates	  the	  age	  (myr,	  million	  years)	  of	  gene	  groups.	  The	  number	  of	  genes	  in	  each	  group	  (from	  old	  to	  young):	  11934,	  1239,	  914,	  597,	  876,	  1195,	  279,	  175,	  198,	  315,	  926,	  and	  1143.	  Solid	  red	  dots	  and	  blue	  circles	  indicate	  sites	  on	  the	  sense	  and	  antisense	  strands,	  respectively.	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Table	  S1	  
	  	  	   	  
Oligonucleotides for 3’-end sequencing and 3’-RACE. (T)24 denotes the 24 ‘T’ nucleotides at 












GeneRacer oligo-dt (RT) GCTGTCAACGATACGCTACGTAACGGCATGACA
GTG(T)24
GeneRacer™ 3 Primer GCTGTCAACGATACGCTACGTAACG
GeneRacer™ 3 Nested Primer CGCTACGTAACGGCATGACAGTG
Pgm2_Gsp-1 GGTCTATGGGAGAAGAGAGAACAGG
Pgm2_Gsp-2 GATCAAGAACTTCAGAAAACCCTGACC
Ccm2_Gsp-1 GGA CAT GGT TCA AGA GGC TCC TTC G
Ccm2_Gsp-2 GTT CAA GAG GCT CCT TCG TTT CTG TAG
Zcchc2_Gsp-1 CTG CCG GTC AAG AGT TCT TGG C
Zcchc2_Gsp-2 GAG TTC TTG GCA TGC TGT TTG TCA GTC C
Mapk4_Gsp-1 GGA TTG CTG CCA ATG CCT AGT AAC CTG
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Table S2 
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Tables S3 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  WT	  Pooled	  
             
                  Summary statistics for cleavage sites identification and filtering 
 
!"#$%&'()&*+,,"-.&*/"0*01*&23-&1$%"4"5%&*6/%*&67%8091"038&"87&9$/%-685
                               WT pooled
unique cleavage sites mapped reads
starting reads/3' ends 1598504 113951376
after internal priming filter 1173847 102627131
after PAS filter 953864 99043279
potential false positive 86425 389185
after removing potential false positive sites 867439 98654094
B2 repeat associated sites 33696 357080
after removing B2 repeat associated sites 835942 98411432
                             WT 1
starting reads/3' ends unique cleavage sites mapped reads
after internal priming filter 1263848 45503131
after PAS filter 929350 40427355
potential false positive 744611 38569397
                             WT 2
starting reads/3' ends unique cleavage sites mapped reads
after internal priming filter 752851 68448245
after PAS filter 566827 62199776
potential false positive 500472 60473882
                              Scr 1
starting reads/3' ends unique cleavage sites mapped reads
after internal priming filter 1588278 34759636
after PAS filter 1004222 28408510
potential false positive 804486 24500514
                              Scr 2
starting reads/3' ends unique cleavage sites mapped reads
after internal priming filter 1964575 75570463
after PAS filter 1366425 65708494
potential false positive 1039972 57343146
                              U1 1
starting reads/3' ends unique cleavage sites mapped reads
after internal priming filter 1349625 20695978
after PAS filter 844187 16704681
potential false positive 683584 14292669
                              U1 2
starting reads/3' ends unique cleavage sites mapped reads
after internal priming filter 2443769 75100565
after PAS filter 1584859 61525590
potential false positive 1193338 53109971
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Tables S4 
                    
Distribution of PAS hexamers at experimentally detected 3’-ends. PAS hexamers used at all 
cleavage sites (Supplementary Figure 1d) or from cleavage sites restricted to the upstream 
antisense region (Supplementary Figure 5a). A red box is placed around the two most highly 
used PAS hexamers (AAUAAA and AUUAAA). All numbers are rounded to the nearest 10th 
decimal place. The PAS usage distribution at all cleavage sites and from upstream antisense 
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   Figure S1 
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Supplementary Figure 1. Mapping the 3’ ends of polyadenylated RNAs by deep sequencing 
in mESCs. (a) Venn diagram depicts the overlap of unique cleavage sites between two 3’-end 
libraries that were constructed and denoted as library replicate 1 and replicate 2.  (b) The fraction 
of cleavage sites in six non-overlapping categories including: 2 kb flanking 3’ end of the gene (3’ 
end), 5 kb downstream the TSS in the gene (5’ end), internal of the gene (Internal, not 5’ end or 3’ 
end), upstream antisense of the TSS within 5 kb (Upstream antisense), antisense to the gene 
(Antisense), and other intergenic regions (Intergenic) in pool (combining replicate 1 and 2), 
replicate 1, replicate 2, overlap (only common to replicate 1 and 2), and sites unique to replicate 1 
or replicate 2.  (c) Density of unique cleavage sites at annotated 3’ ends of genes with sense and 
antisense sites shown in red and green, respectively. Position zero denotes the annotated TES. 
Average coverage equals the number of unique cleavage sites per nucleotide per gene. (d) Pie 
chart displaying the usage of each PAS (all percentages shown in Supplementary Table 4a) among 
all unique cleavage sites. (e) Histogram showing the distance of the PAS (all 36 hexamers) 5’ end 
relative to the cleavage site (indicated as position zero on the x-axis) and fraction of all cleavage 
sites that have a PAS at each position is shown on the y-axis. 
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Figure S2 
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Supplementary Figure 2. The cleavage bias near gene TSS is conserved in various tissues in 
mouse and human. To determine if the bias found in mouse ES cells can be observed in other 
mouse tissues or another mammalian species, we examined published 3’-end sequencing data. 
Panels display metagene plots of sense (red) or antisense (green) unique cleavage sites flanking 
coding gene TSS. The number of unique cleavage sites in each 25 bp bin across 5 kb upstream 
and downstream of the TSS is plotted and unique cleavage sites within 5 kb of annotated 3’-ends 
were removed. In all tissues of human and mouse, we observed more upstream antisense cleavage 
and a promoter proximal antisense peak. Despite different sets of genes being expressed across 
various tissues and analyzing 3’-end sequencing data generated from another mammalian species, 
the pattern is consistent with the biased distribution of PAS and U1 sites that is generally encoded 
in gene sequences.
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Figure S3 
    
Divergent promoters Without nearby genes Pol II Ser5p bounda b c
d
cleavage atSS
eCleavage cluster Cleavage reads
5 reads per site
2 reads per sitef
g
Supplementary Figure 3. Metagene analysis of cleavage sites near gene TSS. Displayed 
metagene plots (a-g) were generated in the same way as Figure 1a with the specified 
modifications. (a) Plot focusing on divergent promoters (details in methods), (b) or a subset of 
promoters where the gene is at least 6 kb in size and there are no other TSS or TES within the 10 
kb window. Unlike Figure 1a, sites within 5 kb of TES were not removed. (c) A plot displaying a 
subset of promoters that showed significant Ser5 phosphorylated Pol II peaks in mESCs. For 
metagene plots a-c, only unique cleavage sites are being plotted.  (d) Plotting the density of 
unique cleavage clusters (cleavage sites within 24 bps were clustered together and the most 5’ 
sites are used as a reference site of the cluster). (e) Plotting read density instead of unique cleav-
age sites. Sites with more than 500 supporting reads were removed from the plot since they could 
be unannotated gene ends. Metagene plots (f-g) were generated in the same way as Figure 1a 
except taking a subset of unique cleavage sites with at least two (f) or five (g) supporting reads. 
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Figure S4 











































Supplementary Figure 4. Validation of promoter proximal antisense (a-b) and sense (c-d) 
cleavage sites using 3’-RACE. Each panel displays a genome browser view of the promoter 
proximal region at four coding genes: Mapk4 (a), Zcchc2 (b), Ccm2 (c), Pgm2 (d) with the gene 
TSS denoted with a black arrow pointing towards the right. Promoter proximal 3’-end cleavage 
reads for uaRNA (blue) and mRNA (red) are displayed above each gene schematic shown in black. 
The assayed cleavage site is denoted with an asterisk and the number of reads supporting each site 
is displayed above each site. We validated the most prominent cleavage site (supported by the most 
number of reads) for each uaRNA loci.  Agarose gels of 3’-RACE PCR products are displayed to 
the right and each assayed cleavage site (asterisk) was cloned and sequenced using Sanger 
sequencing methods. Scale bars are represented in black above genes. The encoded genome 
sequence is displayed including the sequence of the PAS (bold) and the distance between the 
cleavage site (blue and red arrow for uaRNA and mRNA, respectively) and the 5’-end nucleotide 
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Supplementary Figure 5. Upstream antisense cleavage sites resemble annotated gene TES. (a) 
Pie chart displaying the usage of each PAS among unique cleavage sites in the upstream antisense 
region. (b) Histogram showing the distance of the PAS 5’ end relative to the cleavage site indicated 
as position zero. For (a-b), figures include all 36 PAS hexamers with the percentage of all PAS 
hexamers in (a) described in Supplementary Table 4b. (c-e) The nucleotide frequency flanking 
cleavage sites (position 0): annotated end of genes (c), cleavage sites detected from our 3’ end 
sequencing -- sites within 2 kb of annotated gene ends (d), and upstream antisense sites (e).
d
Annotated 3!ends
Sequenced 3!-ends Upstream antisense sites
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Figure S6 




Supplementary Figure 6. Binding profiles of ten 3' end processing factors around cleavage 
sites in uaRNA regions and mRNA ends. A cleavage site is defined as a uaRNA cleavage site if it 
is outside any protein coding gene but locates within 5 kb upstream antisense of a protein-coding 
gene TSS. mRNA cleavage sites are defined as cleavage sites within 100 bases of annotated 
protein-coding gene ends. For each 3' end processing factor, CLIP read density within 200 bases of 
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Figure S7 









Supplementary Figure 7. Proximal U1 sites are associated with uaRNA length. (a) Distribu-
tion of cleavage sites flanking strong U1 sites (position 0). Cleavage sites are classified as rare, 
medium, and frequent sites based on the number of reads supporting each cleavage site (rare: 1 
read, medium: 2-9 reads, frequent: >9 reads). Y-axis is shown as the fraction of sites per gene per 
base. (b) CDF plot comparing the length of uaRNAs grouped by the presence/absence of promoter 
proximal PAS and U1 sites. PAS+/- (U1+/-) indicates the presence/absence of PAS or U1 sites in 
the first 1 kb of uaRNA region. The length of uaRNAs is estimated using the distance from cleav-
age sites to coding gene TSS.  
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Figure S8 








U1 protection = +500
U1 protection= +2000
PAS only U1 protection = +1500
Supplementary Figure 8. Cleavage site simulation near coding gene TSS. Plots were generated 
in the same way as Figure 2d with unique simulated cleavage sites being plotted. Above each 
simulation plot, U1 protection refers to the zone of protection in nucleotides downstream (+) 
conferred by a strong U1 site. Metagene plot of simulated cleavage events considering the PAS 
(AATAAA) alone (a), or parameters where a PAS is protected if it contains a strong U1 site at least 
500 (b), 1500 (c), or 2000 (d) nts upstream. These data demonstrate that the cleavage bias from the 
simulation is robust when considering protection zones of various sizes. 
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Figure S9 




















































































Supplementary Figure 9. Density of U1 and PAS signals at coding genes and intergenic 
regions. The density of strong U1 sites (a) and AAUAAA polyadenylation signals (b) in sites per kb 
for protein-coding genes longer than 15 kb and flanking 15 kb of intergenic sequences. U1 or PAS 
signals located on sense or antisense regions are depicted in purple and black, respectively. In 
addition to the strong U1 enrichment in the proximal sense direction of the gene, we observe a 
modest increase in the frequency of strong U1 signals internal to genes. We also observed a strong 
strand bias of PAS in coding transcription units, both exon and intron sequences, as compared to 
intergenic regions. Specifically, PAS are depleted on the sense strand when compared to the 
antisense strand throughout coding genes prior to the TES. In absolute terms, the genome back-
ground has a relatively high density of PAS (~ 2 sites per kb on average) but lower density of strong 
U1 sites (~0.5 sites per kb on average). Together, the observed distributional patterns support a 
general model of a U1-PAS axis favoring elongation to produce long transcripts such as precursors 
to mRNA but limiting transcription from antisense and intergenic regions.
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Figure S10 
    
 






















































































































































































Supplementary Figure 10. U1-PAS axis at mRNA:mRNA and lncRNA:mRNA gene pairs. 
1047 and 629 mRNA:mRNA and lncRNA:mRNA gene pairs, respectively, were analyzed similarly 
as in Fig 1a, Fig. 2a, and Fig. 2c, except that larger bins were used (500 bps bin for PAS and 100 
bps bin for U1) to smooth the curve due to the low number of genes used to make the plot. For 
mRNA:mRNA gene pairs position zero represents the TSS of all genes on the + strand. For 
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Figure S11 
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RNAPII RNAPII
5’SS







Supplementary Figure 11. Illustration of the U1-PAS axis for divergent non-coding RNA 
control. At divergent promoters, RNAPII (depicted as a purple oval) transcribes in both 
downstream sense and upstream antisense directions, yet upstream antisense RNAs are 
frequently terminated shortly after initiation due to the high density of PAS (red stop sign) and 
a lack of strong U1 signals to suppress these sites. In contrast, PAS signals are low in the 
downstream sense direction and are generally protected by the binding of U1 snRNP (green 
hexagon) to a nearby 5’ splice site denoted as 5’SS in black.  A pink stop sign denotes a 
protected PAS. The U1-PAS axis may function to promote continued elongation throughout 
the gene and to ensure transcription is suppressed outside protein-coding genes.  
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Although RNAPII initiates transcription divergently at most gene promoters, it has been 
unclear why a full-length stable mRNA molecule is not produced in the upstream antisense 
direction of gene promoters similar to a coding sense mRNA. In Chapter 2 of this thesis we 
focused on the characterization of uaRNAs from a small cohort of divergent promoters in 
mESCs. This analysis demonstrated that the previously identified TSSa-RNAs are part of longer 
transcripts (not the 5’-ends) we refer to as uaRNA. uaRNAs are less than 1 kb in size, capped at 
their 5’-ends, heterogeneous at their 3’-ends, and are expressed at 1-4 copies per cell at the 
steady state. In addition, uaRNAs are unstable with half-lives of 15-20 minutes. This is due, in 
part, to uaRNA being targeted for degradation by the RNA exosome since we show their levels 
and size increase upon inactivation of a core exosome component.  Surprisingly, we also find 
that uaRNA are sensitive to NELF/DSIF (pausing factors) knockdown and flavopiridol treatment 
(inhibitor of P-TEFb) since their levels increase and decrease, respectively, indicating that the 
antisense RNAPII complex undergoes pausing and is released from the paused state via 
recruitment and activity of P-TEFb. That uaRNA overcome the pausing barrier and proceed to 
the initial stages of productive elongation was unexpected, given the lack of H3K79me2 and 
H3K36me3 in the upstream antisense region of gene promoters.  In addition, upon induction of 
the Isg20l1 gene, we found a comparable rate of change in mRNA and uaRNA over several time 
points, suggesting uaRNA and mRNA may be transcribed with similar kinetics. Altogether, the 
data in Chapter 2 suggested that the mechanism regulating promoter directionality likely occurs 
after P-TEFb recruitment and may involve premature termination followed by degradation by the 
RNA exosome. We suspect that the uaRNA cloned and sequenced in Chapter 2 likely represent 
degradation products for the following reasons: uaRNA are exosome substrates and that uaRNA 
ends are heterogeneous and non-polyadenylated. Because early transcription events were similar 
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between uaRNA and mRNA, it seemed probable that, like their sense counterparts, uaRNA may 
undergo PAS-dependent transcription termination.  
In Chapter 3, we explored the possibility that promoter directionality, in mammals, is 
controlled by regulating PAS-dependent transcription termination. To test this, we utilized a 
high-throughput sequencing technique to capture the 3’-ends of polyadenylated RNAs in 
mESCs. Interestingly, we detected 2-fold more upstream antisense cleavage sites compared to 
downstream sense cleavage sites in the promoter-proximal region flanking all coding gene TSSs 
(Chapter 3, Figure 1), suggesting uaRNA may undergo early termination shortly after being 
transcribed. Consistent with uaRNA terminating using PAS-dependent mechanisms, we also 
detect the binding of canonical cleavage and polyadenylation factors near uaRNA cleavage sites 
(Chapter 3, Supplementary Figure 6).  
In addition, we find an asymmetric distribution of U1 and PAS signals flanking gene 
TSSs (Chapter 3, Figure 2). These observations are consistent with a known role for U1 snRNP 
binding in suppressing downstream PAS signals (Berg et al., 2012; Kaida et al., 2010). Indeed, 
functional inhibition of U1 snRNP using morpholinos led to a drastic increase in proximal sense 
cleavage sites where U1 signals are high and modest increases in cleavage sites in the upstream 
antisense direction where U1 signals are low. These data reveal that under normal conditions, 
sense proximal U1 signals function to suppress proximal sense termination signals.  
Lastly, we show evidence for evolutionary selection on the U1-PAS axis in vertebrates. 
First, we demonstrated a selection for high U1 and low PAS signals in the first 1 kb of genes 
throughout vertebrate evolution, such that, as genes age (or have more time to evolve) they 
acquire more U1 and less PAS signals at the 5’-end. The selection for U1 signals in the first 1 kb 
of genes is likely to reflect the pressure to suppress proximal termination (Chapter 3, Figure 4A). 
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Interestingly, a similar trend, albeit weaker, is also observed in the upstream antisense region of 
gene TSSs, indicating the selection for some uaRNAs to retain U1 signals. This is consistent 
with a recent study that indicates that the majority of long-noncoding RNAs (LncRNAs) 
expressed in mouse and human embryonic stem cells arise from divergent transcription and 
about a quarter of the divergent lncRNAs are spliced (Sigova et al., 2013). Second, we propose 
an evolutionary relationship between uaRNA, lncRNA, and mRNA at bidirectional promoters 
(Chapter 3, Supplementary Figure 10). For example, lncRNA:mRNA gene pairs have a weaker 
bias (in terms of cleavage pattern, U1 signals, and PAS signal) than uaRNA:mRNA gene pairs 
but stronger than mRNA:mRNA gene pairs. These findings beg the question whether some 
uaRNAs over time are selected to become longer non-coding RNA. We also suggest the U1-PAS 
axis may extend past regions proximal to gene TSSs, as we reveal that the enrichment of U1 
signals and depletion of PAS extends throughout the coding gene, whereas intergenic regions are 
relatively low in U1 and high in PAS signal (Chapter 3, Supplemental Figure 9). 
To conclude, in this thesis we have uncovered a mechanism to explain why full-length 
mRNAs are not produced in the upstream antisense direction of divergent mammalian promoters 
through a detailed structure and sequence analysis of uaRNA at the gene and genome-level. We 
demonstrate that promoter directionality is encoded in the DNA sequence as a U1-PAS axis and 
that this mechanism likely extends throughout the genome. Not only does the U1-PAS axis 
ensure coding genes are read in the correct direction, but likely serves as a mechanism to 
suppress transcription outside of coding genes. Although it seems paradoxical to transcribe 
RNAs that will be destroyed shortly after they are transcribed, perhaps pervasive transcription 
serves as a playground for natural selection to occur and, that over time, with the right mutations 
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The mechanism explaining why uaRNAs are targeted for degradation despite acquiring a PAS-
dependent adenylated tail remains elusive. Furthermore, it is unclear why elongation chromatin 
marks, such as H3K79me2 and H3K36me3, are absent in the upstream direction of gene 
promoters where uaRNAs are transcribed. Therefore, in this section these two questions will be 
expanded upon and when appropriate models and hypothesis will be suggested.  
 
Poly (A) tail length and RNA decay  Despite the addition of a PAS-dependent, adenylated tail 
to the 3’-end, uaRNAs are very unstable (15-20 minute half-lives) and rapidly targeted for 
degradation by the RNA exosome (Chapter 2, Figure 2 and Supplementary Figure 7). This is 
surprising given that a PAS-dependent adenylated tail is thought to function in protecting the 3’-
end from nuclear decay machineries (LaCava et al., 2005; Proudfoot, 2011). However, it is 
possible that differences in the length of the poly(A) tail may impact whether the RNA exosome 
or its cofactors have access to the 3’-end. For example, in yeast, a non-canonical poly (A) 
polymerase, either Trf4 or Trf5, is part of the (Trf4/Air2/Mtr4p) TRAMP complex and functions 
to target cryptic unstable transcripts (CUTS) for degradation by recruiting the exosome (LaCava 
et al., 2005; Vanacova et al., 2005). Compared to the canonical Poly (A) polymerase (PAP), Trf4 
displays less processivity and catalyzes the addition of a short oligo (A) tail. Thus, it remains 
possible that uaRNAs acquire short oligo (A) tails that are not large enough to be protected by 
RNA binding proteins, and thus, are subsequently targeted for degradation by the exosome. 
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Consistent with this model, human orthologs of Trf4 and Trf5 (PAPD5 and PAPD7) have been 
linked to the degradation of improperly processed ribosomal RNAs (Shcherbik et al., 2010), 
snoRNA maturation (Berndt et al., 2012), and more recently oligo (A) tails synthesized by 
PAPD5 were detected at the 3’-end of PROMPTs in human cells (Preker et al., 2011). These 
antisense PROMPTs have recently been shown to be the human equivalent of uaRNAs (Ntini et 
al., 2013). On the other hand, the relationship between poly(A) tail length and RNA decay can be 
complicated given that in fission yeast hyperadenylated poly(A) tails (as long as 1 kb) can also 
act as a signal to recruit the exosome for target degradation (Chen et al., 2011). Therefore, 
acquiring the proper tail length may be critical in establishing a stable mRNA and that either 
shorter and, in some cases, longer adenylated tails may mark the transcript as an improperly 
processed mRNA that is subsequently destroyed. Further experimentation to define the length of 
uaRNA poly(A) tails genome-wide will clarify whether they contain a stabilizing 3’-end poly 
(A) tail of a normal mRNA length. 
 
Poly (A) binding protein nuclear 1 (Pab2) and RNA decay  The Pab2, has been established as 
an important 3’-end processing factor. Specifically, early in vitro polyadenylation experiments 
revealed Pab2 interacted with the growing poly (A) tail and the canonical poly (A) polymerase to 
stimulate the addition of roughly 200-250 adenines to the 3’-end of mRNAs (Kerwitz et al., 
2003; Kuhn et al., 2003). Surprisingly recent studies investigating the function and activity of 
Pab2 in vivo demonstrate that upon knockdown (Apponi et al., 2010) or deletion (Hurschler et 
al., 2011; Lemay et al., 2010) of Pab2, expression of mRNAs were unaffected globally. A similar 
observation was made in human cells when Pab2 was knocked down, but more interestingly, a 
subset of long noncoding RNAs arising from divergent transcription were stabilized nearly 2-4 
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fold (Beaulieu et al., 2012). Furthermore, they demonstrated that these lncRNAs displayed short 
half-lives, required the poly(A) tail for degradation, and that the poly (A) binding protein 
recruited the exosome through a direct interaction with hRrp6 (catalytic nuclear component of 
the exosome) to promote target degradation. Interestingly, this stabilization was independent of 
hTrf4 (non-canonical poly (A) polymerase), which has previously been linked to the degradation 
of CUTS in yeast (described above). Therefore, these data represent a new mechanistic link 
between cleavage and polyadenylation and RNA decay involving Pab2. We plan to test whether 
Pab2 functions to selectively recruit the exosome complex to uaRNAs by knocking down Pab2 
in mESCs followed by RNA-Seq to determine whether uaRNA levels are stabilized.  
 
 
Splicing and deposition of active chromatin marks  As mentioned earlier in Chapter 1, 
elongation-specific chromatin marks (H3K79me2 and H3K36me3 ) are largely absent in the 
upstream direction of divergent promoters. One hypothesis that will be elaborated on in this 
section is the possibility that a lack of strong cis- splicing elements (and weak recruitment of 
trans- splicing factors) may result in a failure to recruit chromatin modifiers to the upstream 
antisense region of divergent promoters. Recently, there has been an accumulating amount of 
evidence indicating a link between splicing and the deposition of histone H3 chromatin 
modifications (de Almeida et al., 2011; Kim et al., 2011). For example, genome-wide analysis of 
histone methylation demonstrates that intron-containing genes are marked with higher levels of 
H3K36me3 and splicing inhibition (with spliceostatin) results in less recruitment of Set2d 
(H3K36me3 methyltransferase) and reduced H3K36me3. This data suggests that splicing signals 
recruit histone modifiers to the chromatin when they are needed during the transcription cycle.  
	   139	  
A direct involvement of U1 snRNP in modulating chromatin was revealed in a study that 
demonstrated that strengthening the base pairing between the U1 snRNP and a 5’SS (by either 
mutating the 5’SS or U1 snRNA) resulted in chromatin reorganization when assayed with 
MNase digestions, implicating a role for U1 snRNP in chromatin remodeling (Keren-Shaul et al., 
2013). Therefore, it will be interesting to directly test the role that U1 snRNP plays in the 
deposition of active histone marks by performing genome-wide ChIP-seq on histone H3 upon U1 
snRNP inhibition, focusing on modifications, H3K79me2 and H3K36me3, that are largely absent 
in the upstream antisense region. In parallel, it will be interesting to assess how the insertion of 
5’ splice site sequences in the upstream antisense region, using genome-integrated reporter 
constructs, may impact the deposition of active histone modification.  
 
Additional mechanisms that may impact promoter directionality 
In addition to the U1-PAS axis, there may be other mechanisms to influence 
directionality of transcription, which will be the focus of this section. First, it is possible that 
intrinsic cis-regulatory elements within the promoter sequence may dictate the degree of 
divergent transcription. For example, two major classes of promoters have been described in 
mammals: TATA-containing and TATA-less (often CpG rich). The TATA box was the first 
identified core promoter element and early in vitro studies revealed its functional importance in 
recruiting the transcriptional apparatus to the promoter (Smale and Kadonaga, 2003). However, 
recent computational analysis would argue that at human genes only 24% contain a TATA-like 
box element in the promoter, whereas the other 76% are CpG rich (Yang et al., 2007). 
Interestingly, 77% of bidirectional promoters (instances where two mRNAs share a promoter and 
are in a head-to-head orientation) contain CpG-rich sequences, compared to only 38% of 
	   140	  
unidirectional promoters (Trinklein et al., 2004). Moreover, among divergent promoters (defined 
by the presence of at least 1 sense and antisense TSSa-RNA), 80% are associated with CpG-rich 
sequences (Seila et al., 2008). Together, these data indicate a positive connection between CpG 
island promoters and divergent transcription (bidirectional), and suggest TATA-containing 
promoters may provide directionality of transcription. Consistent with this, small RNA cloning 
performed in fruit flies revealed that 95% of promoter-associated reads mapped in the sense 
direction (compared to 58% at human promoters), indicating a lack of divergent transcription in 
flies (Nechaev et al., 2010). This may be due to the increase in TATA-like sequences in 
Drosophila melanogaster promoters (compared to human), which were observed to strongly 
correlate with unidirectional transcription (Core et al., 2012; FitzGerald et al., 2006). 
Interestingly, TATA containing sequences within CpG island promoters were highly 
unidirectional, indicating the TATA box is dominant in this orientation (Core et al., 2012). 
Further investigation of Drosophila promoters will likely reveal additional cis-elements that 
promote unidirectional transcription that may be less prominent at mammalian promoters.  
 
 Promoter directionality may also be controlled at the level of transcription initiation. For 
example, RNAPII and general transcription factors may be more efficiently recruited in the sense 
direction, leading to more sense transcription. However, several lines of evidence from our work 
and others would argue against this in mammals. First, analysis of promoter-proximal sense and 
antisense GRO-Seq reads display a 50% difference in transcriptionally engaged RNAPII (Core et 
al., 2008), which cannot account for the 10-fold difference between the sense and antisense RNA 
steady-state levels (Sigova et al., 2013). Furthermore, we observe a coordinated increase in both 
sense and antisense RNAs upon induction of the Isg20l1 gene and after release from the 
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transcription inhibitor, flavopiridol (Chapter 2, Fig 4,5). However, its been recently shown that 
promoter directionality in yeast is controlled at the level of initiation, mainly through Ssu72-
dependent gene loops (Tan-Wong et al., 2012). Interestingly, in a Ssu72 and Rrp6 (exosome 
defective) null strain they observe reduced gene looping and detect a dramatic increase in 
upstream antisense transcription, indicating that gene loops function to ensure RNAPII and GTFs 
are efficiently recruited in the sense direction. Although our data would argue against this model, 
we cannot rule out the possibility that at some divergent promoters gene loops function to 
enforce sense transcription.  
   
Another potential mechanism to regulate promoter directionality includes differential 
recruitment of elongation factors in the sense and antisense direction. I focus here on the 
recruitment of P-TEFb, which has been revealed as the elongation factor that functions to release 
RNAPII from the paused state. Prior to the work presented in this thesis, it was presumed that 
uaRNAs were poorly elongated and likely destroyed either prior to or at the level of RNAPII 
pausing. The mapping of NELF and DISF (pausing factors) genome-wide detected a peak of 
both factors upstream of gene TSSs, which indicated that the antisense RNAPII complex 
undergoes RNAPII pausing (Rahl et al., 2010) but likely is never released from the paused state. 
In our studies, I demonstrate at four divergent promoters that uaRNA levels are sensitive to P-
TEFb inhibition, arguing that they are likely released from the paused state via P-TEFb (Chapter 
2, Figure 4) and undergo the initial stages of transcription elongation. However, it is possible that 
at some divergent promoters P-TEFb recruitment may be limiting. For example, an SR protein 
(SC35) was shown to actively recruit P-TEFb to the 5’-ends of genes (Ji et al., 2013; Lin et al., 
2008) and, more recently, was demonstrated to be part of a repressive complex including the 
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7SK noncoding RNA, Hexim1, and P-TEFb (Ji et al., 2013). Interestingly, they find that 5’-
proximal splicing enhancer signals (that bind Sc35) function to release SC35 and P-TEFb from 
the 7SK-repressive complex to promote pause release and gene activation. Thus, it is likely that, 
in addition to 5’SSs, splicing enhancer signals that function to recruit SC35 and P-TEFb are 



















	   143	  
References  
Apponi, L.H., Leung, S.W., Williams, K.R., Valentini, S.R., Corbett, A.H., and Pavlath, G.K. 
(2010). Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA 
biogenesis. Hum Mol Genet 19, 1058-1065. 
 
Beaulieu, Y.B., Kleinman, C.L., Landry-Voyer, A.M., Majewski, J., and Bachand, F. (2012). 
Polyadenylation-dependent control of long noncoding RNA expression by the poly(A)-binding 
protein nuclear 1. PLoS Genet 8, e1003078. 
 
Berg, M.G., Singh, L.N., Younis, I., Liu, Q., Pinto, A.M., Kaida, D., Zhang, Z., Cho, S., Sherrill-
Mix, S., Wan, L., et al. (2012). U1 snRNP determines mRNA length and regulates isoform 
expression. Cell 150, 53-64. 
 
Berndt, H., Harnisch, C., Rammelt, C., Stohr, N., Zirkel, A., Dohm, J.C., Himmelbauer, H., 
Tavanez, J.P., Huttelmaier, S., and Wahle, E. (2012). Maturation of mammalian H/ACA box 
snoRNAs: PAPD5-dependent adenylation and PARN-dependent trimming. RNA 18, 958-972. 
 
Chen, H.M., Futcher, B., and Leatherwood, J. (2011). The fission yeast RNA binding protein 
Mmi1 regulates meiotic genes by controlling intron specific splicing and polyadenylation 
coupled RNA turnover. PLoS One 6, e26804. 
 
Core, L.J., Waterfall, J.J., Gilchrist, D.A., Fargo, D.C., Kwak, H., Adelman, K., and Lis, J.T. 
(2012). Defining the status of RNA polymerase at promoters. Cell Rep 2, 1025-1035. 
 
Core, L.J., Waterfall, J.J., and Lis, J.T. (2008). Nascent RNA sequencing reveals widespread 
pausing and divergent initiation at human promoters. Science 322, 1845-1848. 
 
de Almeida, S.F., Grosso, A.R., Koch, F., Fenouil, R., Carvalho, S., Andrade, J., Levezinho, H., 
Gut, M., Eick, D., Gut, I., et al. (2011). Splicing enhances recruitment of methyltransferase 
HYPB/Setd2 and methylation of histone H3 Lys36. Nat Struct Mol Biol 18, 977-983. 
 
FitzGerald, P.C., Sturgill, D., Shyakhtenko, A., Oliver, B., and Vinson, C. (2006). Comparative 
genomics of Drosophila and human core promoters. Genome Biol 7, R53. 
 
Hurschler, B.A., Harris, D.T., and Grosshans, H. (2011). The type II poly(A)-binding protein 
PABP-2 genetically interacts with the let-7 miRNA and elicits heterochronic phenotypes in 
Caenorhabditis elegans. Nucleic Acids Res 39, 5647-5657. 
 
Ji, X., Zhou, Y., Pandit, S., Huang, J., Li, H., Lin, C.Y., Xiao, R., Burge, C.B., and Fu, X.D. 
(2013). SR Proteins Collaborate with 7SK and Promoter-Associated Nascent RNA to Release 
Paused Polymerase. Cell 153, 855-868. 
 
Kaida, D., Berg, M.G., Younis, I., Kasim, M., Singh, L.N., Wan, L., and Dreyfuss, G. (2010). U1 
snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature 468, 664-
668. 
	   144	  
 
Keren-Shaul, H., Lev-Maor, G., and Ast, G. (2013). Pre-mRNA splicing is a determinant of 
nucleosome organization. PLoS One 8, e53506. 
 
Kerwitz, Y., Kuhn, U., Lilie, H., Knoth, A., Scheuermann, T., Friedrich, H., Schwarz, E., and 
Wahle, E. (2003). Stimulation of poly(A) polymerase through a direct interaction with the 
nuclear poly(A) binding protein allosterically regulated by RNA. EMBO J 22, 3705-3714. 
 
Kim, S., Kim, H., Fong, N., Erickson, B., and Bentley, D.L. (2011). Pre-mRNA splicing is a 
determinant of histone H3K36 methylation. Proc Natl Acad Sci U S A 108, 13564-13569. 
 
Kuhn, U., Nemeth, A., Meyer, S., and Wahle, E. (2003). The RNA binding domains of the 
nuclear poly(A)-binding protein. J Biol Chem 278, 16916-16925. 
 
LaCava, J., Houseley, J., Saveanu, C., Petfalski, E., Thompson, E., Jacquier, A., and Tollervey, 
D. (2005). RNA degradation by the exosome is promoted by a nuclear polyadenylation complex. 
Cell 121, 713-724. 
 
Lemay, J.F., D'Amours, A., Lemieux, C., Lackner, D.H., St-Sauveur, V.G., Bahler, J., and 
Bachand, F. (2010). The nuclear poly(A)-binding protein interacts with the exosome to promote 
synthesis of noncoding small nucleolar RNAs. Mol Cell 37, 34-45. 
 
Lin, S., Coutinho-Mansfield, G., Wang, D., Pandit, S., and Fu, X.D. (2008). The splicing factor 
SC35 has an active role in transcriptional elongation. Nat Struct Mol Biol 15, 819-826. 
 
Nechaev, S., Fargo, D.C., dos Santos, G., Liu, L., Gao, Y., and Adelman, K. (2010). Global 
analysis of short RNAs reveals widespread promoter-proximal stalling and arrest of Pol II in 
Drosophila. Science 327, 335-338. 
 
Ntini, E., Jarvelin, A.I., Bornholdt, J., Chen, Y., Boyd, M., Jorgensen, M., Andersson, R., Hoof, 
I., Schein, A., Andersen, P.R., et al. (2013). Polyadenylation site-induced decay of upstream 
transcripts enforces promoter directionality. Nat Struct Mol Biol. 
 
Preker, P., Almvig, K., Christensen, M.S., Valen, E., Mapendano, C.K., Sandelin, A., and 
Jensen, T.H. (2011). PROMoter uPstream Transcripts share characteristics with mRNAs and are 
produced upstream of all three major types of mammalian promoters. Nucleic Acids Res 39, 
7179-7193. 
 
Proudfoot, N.J. (2011). Ending the message: poly(A) signals then and now. Genes Dev 25, 1770-
1782. 
 
Rahl, P.B., Lin, C.Y., Seila, A.C., Flynn, R.A., McCuine, S., Burge, C.B., Sharp, P.A., and 
Young, R.A. (2010). c-Myc regulates transcriptional pause release. Cell 141, 432-445. 
 
Seila, A.C., Calabrese, J.M., Levine, S.S., Yeo, G.W., Rahl, P.B., Flynn, R.A., Young, R.A., and 
Sharp, P.A. (2008). Divergent transcription from active promoters. Science 322, 1849-1851. 
	   145	  
 
Shcherbik, N., Wang, M., Lapik, Y.R., Srivastava, L., and Pestov, D.G. (2010). Polyadenylation 
and degradation of incomplete RNA polymerase I transcripts in mammalian cells. EMBO Rep 
11, 106-111. 
 
Sigova, A.A., Mullen, A.C., Molinie, B., Gupta, S., Orlando, D.A., Guenther, M.G., Almada, 
A.E., Lin, C., Sharp, P.A., Giallourakis, C.C., et al. (2013b). Divergent transcription of long 
noncoding RNA/mRNA gene pairs in embryonic stem cells. Proc Natl Acad Sci U S A 110, 
2876-2881. 
 
Smale, S.T., and Kadonaga, J.T. (2003). The RNA polymerase II core promoter. Annu Rev 
Biochem 72, 449-479. 
 
Tan-Wong, S.M., Zaugg, J.B., Camblong, J., Xu, Z., Zhang, D.W., Mischo, H.E., Ansari, A.Z., 
Luscombe, N.M., Steinmetz, L.M., and Proudfoot, N.J. (2012). Gene loops enhance 
transcriptional directionality. Science 338, 671-675. 
 
Trinklein, N.D., Aldred, S.F., Hartman, S.J., Schroeder, D.I., Otillar, R.P., and Myers, R.M. 
(2004). An abundance of bidirectional promoters in the human genome. Genome Res 14, 62-66. 
 
Vanacova, S., Wolf, J., Martin, G., Blank, D., Dettwiler, S., Friedlein, A., Langen, H., Keith, G., 
and Keller, W. (2005). A new yeast poly(A) polymerase complex involved in RNA quality 
control. PLoS Biol 3, e189. 
 
Yang, C., Bolotin, E., Jiang, T., Sladek, F.M., and Martinez, E. (2007). Prevalence of the 
initiator over the TATA box in human and yeast genes and identification of DNA motifs 
enriched in human TATA-less core promoters. Gene 389, 52-65. 
 






	   146	  
Appendix 
 
Divergent transcription of long noncoding 
RNA/mRNA gene pairs in embryonic stem cells 
 
 
Alla A. Sigova, Alan C. Mullen, Benoit Molinie, Sumeet Gupta, David A. Orlando, Mathew 
Guenther, Albert E. Almada, Charles Lin, Phillip A. Sharp, Cosmas C. Giallourakis, and Richard 
A. Young 
 
Author contributions:  I contributed experimental data, validating the sequence and structure of 
divergent lncRNAs, to the following work previously published as: 
 
Alla A. Sigova, Alan C. Mullen, Benoit Molinie, Sumeet Gupta, David A. Orlando, Mathew 
Guenther, Albert E. Almada, Charles Lin, Phillip A. Sharp, Cosmas C. Giallourakis, and Richard 
A. Young. (2013). Divergent transcription of long noncoding RNA/mRNA gene pairs in 
embryonic stem cells. Proc Natl Acad Sci U S A 110, 2876-2881 
 
 
 
 
 
 	  
